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Burkholderia pseudomallei is the causative agent of melioidosis. Currently no 
vaccines are available and not much is known about the mechanisms of adaptive 
immunity to the bacterium. In this project, in vitro systems were employed to study 
interactions of the bacteria with host T cells. B. pseudomallei is able to invade and 
replicate intracellularly in T cells and dendritic cells. We found that bacteria do not 
induce rapid cell death in infected T cells as in dendritic cells. In fact, bacterial infection 
modulates T cell function by enhancing IL-2 production upon the engagement of the T 
cell receptor.  Further studies reveal bacterial flagellin as a potent costimulatory molecule 
of T cell activation.  However, flagellin is not the major contributor to T cell 
costimulation during live bacterial infection as determined by flagellin null mutant 
bacteria.  The direct coactivation of T cells by B. pseudomallei could contribute to severe 




































































Burkholderia pseudomallei, discovered by Whitmore and Krishnaswani in 1912, is a 
free-living Gram-negative bacterium found in the soil and surface water (Whitmore and 
Krishnaswami, 1999). It is the causative agent for melioidosis, a disease that is 
predominantly endemic in Southeast Asia, particularly Thailand as well as northern 
Australia (Dance, 1991, Thomas, 1981, Rode and Webling, 1981, Nachiangmai et al., 
1985, Charoenwong et al., 1992). Most cases occur during the rainy season when the 
bacterium is found most frequently in surface water and soil shortly after rainfall 
(Leelarasamee and Bovornkitti, 1989, Ashdown, 1979). Infection can occur through 
inhalation of aerosolized infectious particles, ingestion or contact of damaged skin 
surfaces or wounds with infectious agents found in contaminated soil or water (Currie et 
al., 2000). Melioidosis is also endemic in Singapore, where the bacterium has been 
previously isolated from soil and drain water (Thin et al., 1971). Being associated with 
high mortality rates, it is a disease of concern in the country. An average of 59 cases were 
reported each year with an average annual fatality rate of 27.4 % during the period 1990 
to 2003 (Ministry of Health, Singapore Communicable Diseases Surveillance in 
Singapore 2003, Singapore, 2004). Moreover, B. pseudomallei is classified as a category 
B bioterrorism agent by the Centers for Disease Control and Prevention (CDC) 
(www.bt.cdc.gov/agent/agentlist.asp). 
 Melioidosis is a disease with diverse clinical manifestations. It can be categorized 
into acute, subacute and chronic infections (Currie et al., 2000). The disease is often 
associated with pneumonia-like symptoms such as fever and cough (Poe et al., 1971). 
The most severe form is acute septicaemic melioidosis, usually associated with bacterial 
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dissemination to distant sites leading to abscesses in organs such as the liver and spleen 
as well as other organs (Puthucheary et al., 1981 and 1992, Vatcharapreechasukul et al., 
1992). Latent infections, whereby initial exposure to the pathogen is followed by a 
prolonged incubation period of even up to 62 years in one patient, have been documented 
(Mays and Ricketts, 1975, Chodimella et al., 1997, Ngauy et al., 2005). Recurrence of 
disease after apparently successful antibiotic treatment is also commonly seen 
(Chaowagul et al., 1993, White, 2003). Disease relapse could likely be due to reactivation 
of a persistent endogenous bacterial source such as within abscesses in the liver or spleen 
(Mays and Ricketts, 1975, Kanai and Dejsirilert, 1988, Desmarchelier et al., 1993). The 
majority of relapse cases is due to reactivation of the original infecting strain, though 
infection with different strains was demonstrated in some patients (Desmarchelier et al., 
1993, Vadivelu et al., 1998). Asymptomatic conditions or subclinical infections also 
occur where healthy individuals have positive serological tests indicating prior exposure 
to the pathogen (Kanaphun et al., 1993, Currie et al., 2000). Risk factors predisposing to 
melioidosis include diabetes, alcoholism and chronic lung or renal disease (Leelarasamee 
and Bovornkitti, 1989, Brett and Woods, 2000, Currie et al., 2000). 
Treatment and diagnosis  
B. pseudomallei is known to develop resistance to many commonly used 
antibiotics, including quinolones and macrolides as well as third generation 
cephalosporins, penicillins and aminoglycosides (Dance et al., 1989, White, 2003, Cheng 
and Currie, 2005). Currently, initial treatment employs intravenous administration of 
ceftazidime and carbapenem antibiotics (imipenem and meropenem). The oral antibiotic 
TMP-SMX, with or without doxycycline and chloramphenicol is used for the prolonged 
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eradication phase (White et al., 1989, Sookpranee et al., 1992, Smith et al., 1996, Jenney 
et al., 2001, Chetchotisakd et al., 2001). However, relapse is still seen in some patients 
likely due to reactivation of persistent endogenous bacterial source. Antibiotic therapy 
would also be less efficient once the bacteria gain residence within intracellular 
compartments (Kanai and Dejsirilert., 1998, Jones et al., 1996, Chaowagul et al., 1993).  
With protean clinical manifestations that often mimic that of other diseases, 
melioidosis needs to be diagnosed early to ensure prompt treatment. The standard 
diagnosis is the isolation of B. pseudomallei from bodily fluids of patients using culture-
based methods. This requires the use of selective media such as the commonly used 
Ashdown medium (tryptase soy agar, glycerol, crystal violet, neutral red and 
gentamycin), now modified with colistin (Ashdown, 1979, Dance et al., 1989). The use 
of B. pseudomallei selective agar (BPSA) has also been recently described (Howard and 
Inglis, 2003). However, diagnosis using conventional media-based blood culture is time 
consuming. By the time culture positivity is indicated, bacteriamia would have occurred 
resulting in mortality. Alternative methods such as isolator lysis centrifugation provide a 
shorter time to positivity but sensitivity is compromised (Simpson et al., 1999). 
Apparently a reliable means to identify B. pseudomallei, the Vitek automated system has 
also been tested (Lowe et al., 2002). To reduce time to diagnosis, techniques such as 
antigen detection, antibody detection and molecular techniques have been employed. A 
monoclononal antibody latex agglutination test against a 200-kDa protein that could 
agglutinate B. pseudomallei positive blood culture fluid is currently widely used in 
Thailand (Anuntagool et al., 2000). Indirect Haemagglutination Assay (IHA) to detect 
antibodies remains the most widely used test. However, IHA poses a problem in endemic 
 16 
regions where subclinical infections are commonly encountered with around 80 % of 
people who are healthy and seropostive by the age of 4 years (Khupulsup and Petchclai, 
1986, Kanaphun et al., 1993). IHA is also associated with poor sensitivity and specificity 
(Sirisinha et al., 2000). Others have developed molecular methods such as PCR 
techniques to detect 16S RNA and 23S rRNA using specific-primers (Brook et al., 1997, 
Dharakul et al., 1996, Kunakorn et al., 2000, Rattanathongkom et al., 1997, Sirisinha et 
al., 2000). Reasonable sensitivity and specificity is also seen with Enzyme-Linked 
ImmunoSorbent Assays (ELISA) to detect B. pseudomallei proteins or monoclonal 
antibodies against cell wall components (Wongratanacheewin et al., 1993, Dharakul et 
al., 1999, Pongsunk et al., 1999).  
Pathogenesis of Burkholderia pseudomallei 
Over the past decade, B. pseudomallei is increasingly catching the attention of 
scientists whose work are beginning to shed light on the molecular pathogenesis of this 
bacterium. B. pseudomallei can invade and replicate in both non-phagocytic cells such as 
epithelial cells as well as phagocytic cells including macrophages and neutrophils 
(Kespichayawattana et al., 2004, Pruksachartvuthi et al., 1990, Jones et al., 1996, Harley 
et al., 1998). The bacterium is apparently capable of escaping phagosome-lysosome 
fusion after ingestion by phagocytes (Harley et al., 1998). It can also evade macrophage-
mediated killing by interfering with inducible nitric oxide synthase (iNOS) and Tumour 
Necrosis Factor alpha (TNF-α) production (Utaisincharoen et al., 2000 and 2001). Once 
within the host cell, B. pseudomallei can also induce death of host cells through a 
caspase-1-dependent mechanism (Sun et al., 2005).  
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Many virulence factors of B. pseudomallei have been recognized. Firstly, B. 
pseudomallei possess three Type III Secretion Systems (TTSS) gene clusters. The TTSS 
3, also known as Burkholderia secretion apparatus (bsa), has been shown to be required 
for full virulence in a hamster infection model (Warawa and Woods, 2005). This gene 
cluster encodes for a secretion apparatus and several secreted effectors. It exhibits 
homology to the TTSS found on the SP-1 pathogenicity island from Salmonella enterica 
that is needed for cellular invasion (Attree and Attree, 2001, Stevens et al., 2002). Type 
III-encoded translocator proteins associates with the host cell membrane and type III 
effector proteins are being translocated into the host cell cytosol (Cornelis et al., 2000). 
One B. pseudomallei type III effector, BopE, is homologous to Salmonella enterica 
SopE/ SopE2 and found to facilitate bacterial invasion of epithelial cells (Stevens et al., 
2003). BipD gene encodes a component of the B. pseudomallei translocation apparatus 
and BipD mutants show attenuated virulence with impaired ability to replicate in the liver 
and spleen of infected BALB/c mice (Stevens et al., 2004). B. pseudomallei BipB was 
shown to induce apoptosis and formation of multi-nucleated giant cells of infected cells 
(Suparak et al., 2005).  
 B. pseudomallei capsular polysaccharide and flagella have also been associated 
with virulence (Reckseidler et al., 2001, Chua et al., 2003). In the presence of normal 
human serum, phagocytosis was more efficient for the acapsular mutant (Atkins et al., 
2002). This correlates to a recent study demonstrating reduced deposition of complement 
factor C3b on bacterial surface, hence promoting their survival in the host circulation 
(Reckseidler et al., 2005). The capsule might also act as a barrier to prevent recognition 
of the complement-oposonized bacteria by complement receptor expressed on phagocytes 
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(Reckseidler et al., 2001). This data is in line with a previous study that showed B. 
pseudomallei resistance to complement-mediated lysis (Egan and Gordon, 1996). 
Although afflagellate mutant was still capable of invading and replicating in lung 
epithelial cells, it was found to be less virulent in an intraperitoneal and intranasal mouse 
model of infection, indicated by higher LD50 values compared to the wild type (Chua et 
al., 2003). Other putative virulence factors include B. pseudomallei Type IV pili involved 
in bacterial adherence, endotoxin lipopolysaccharide (LPS) that is less capable of 
activating mouse macrophages compared to E. coli LPS as well as B. pseudomallei 
quorum-sensing system-controlled virulence factors and processes (Essex-Lopresti  et al., 
2005, Utaisincharoen  et al., 2000, Ulrich et al., 2004, Chan and Chua, 2005).  
Host immunity to bacteria 
During the initial encounter with pathogens, innate immune cells such as 
monocytes, neutrophils and dendritic cells (DCs) recognize pathogen-associated 
molecular patterns (PAMPs) expressed on the bacteria through pattern recognition 
receptors (PRR) such as Toll-like receptors (TLR) and scavenger receptors. They then 
become activated to kill the pathogen. B. pseudomallei have several candidate TLR 
ligands such as LPS (TLR4), peptidoglycan (TLR2), flagellin (TLR5) and CpG DNA 
(TLR9). To date, little is known about the role of TLRs in B. pseudomallei infection. 
TLRs are important initiators of innate immunity as well as integral links between innate 
and adaptive immunity. For instance, DCs require TLR signals to undergo maturation 
into cells capable of presenting captured antigens to T cells (Kaisho and Akira, 2000, 
Takeda et al., 2003, Pearce et al., 2006). T cell activation requires both antigenic signals 
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as well as costimulatory signals provided by professional antigen presenting cells such as 
DCs (Jenkins et al., 1990, Johnson and Jenkins, 1993).  
The pro-inflammatory cytokine Inteferon-gamma (IFN-γ) is important for early 
host resistance against B. pseudomallei infection (Santanirand et al., 1999). NK cells and 
T cells have been found to be major sources of early IFN-γ (Haque et al., 2006). A recent 
study showed that B. pseudomallei could suppress IFN γ -responses in infected mouse 
macrophages by activating suppressor of cytokine signaling 3 (SOCS3) and cytokine-
inducible Src homology 2-containing protein (CIS) (Ekchariyawat et al., 2005). In 
comparison with BALB/c mice, C57BL/6 mice are more resistant to B. pseudomallei 
infection. Bacterial counts in C57BL/6 mice were decreased 12 h after infection 
compared to BALB/c mice, which suggests that lower susceptibility of C57BL/6 mice 
could be due to their ability to develop innate immune responses during the early phase 
of B. pseudomallei infection (Hoppe et al., 1999, Liu et al., 2002). BALB/c mice were 
shown to succumb to septicemic infection with organ inflammation due to overwhelming 
high bacterial loads (Leakey et al., 1998, Hoppe et al., 1999, Liu et al., 2002). A transient 
hyperproduction of IFN-γ was seen in BALB/c mice, which correlated to disease severity 
(Liu et al., 2002). Hence, uncontrolled proinflammatory responses could also result in 
disease pathology. Clinical support for hyperinflammation in melioidosis patients 
includes elevated serum concentrations of pro-inflammatory cytokines such as IL-6 and 
IFN-γ in patients with septicemic melioidosis (Simpson et al., 2000, Brown et al., 1991). 
The elicitation of adaptive immune responses is believed to be important during 
infection with intracellular pathogens such as B. pseudomallei (Raupach et al., 2001, 
Healey et al., 2005). Recent clinical studies by Keethesan and coworkers (2002) have 
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shown that lymphocytes taken from patients who have recovered from melioidosis show 
enhanced proliferation and IFN-γ production in response to B. pseudomallei antigens. 
This demonstrates the development of cell-mediated (CMI) immune responses in infected 
patients. Their data also suggest the importance of CMI for protection against disease 
progression in seropositive but healthy individuals and that patients could succumb to 
infection as a result of inadequate CMI responses (Ketheesan et al., 2002, Barnes et al., 
2004). B. pseudomallei could prime both antigen-specific CD4+ and CD8+ T cells, 
reflected by enhanced IFN-γ production in response to heat killed bacteria by these cells 
taken from infected mice (Haque et al., 2006). In particular, CD4+ T cells are important 
for late host resistance to B. pseudomallei in mouse infection models (Haque et al., 
2006). Therefore, T cell-mediated adaptive immune responses and their production of 
cytokines are believed to be important for control of B. pseudomallei infection (Healey et 
al., 2005, Haque et al., 2006).  
Project aims 
Knowledge of the pathogenesis of B. pseudomallei is essential to facilitate 
therapeutic developments. Our objective is to gain insights into the pathogenesis of the 
bacteria by employing the use of in vitro culture systems to study the interactions of B. 
pseudomallei and immune cells. T cells play an important role in cell-mediated responses 
while dendritic cells, being professional antigen presenting cells necessary for priming 
naïve T cells, are important initiators of adaptive immunity. One of the most direct means 
to subvert host immune defenses involves inducing death or disrupting the functions of 
such immune cells in the infected host. Interestingly, previous work in the laboratory 
suggests that T cells seem to be able to control bacterial intracellular replication at early 
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stages of infection. DNA laddering, a characteristic feature of apoptosis, was not 
observed in T cells at 24 hours after infection compared to other cell types. One of the 
aims is to examine the ability of B. pseudomallei to invade and replicate intracellularly in 
T lymphocyte and dendritic cell lines. We also want to determine whether viability of the 
infected cells was affected as a result of B. pseudomallei infection.  Currently little is 
known if B. pseudomallei could directly modulate T cell function despite the pathogen 
being known to interfere with cellular functions of phagocytic cells such as macrophages. 
Another aim is thus to examine whether B. pseudomallei could affect cytokine production 
by T cell lines in response to T cell receptor (TCR) stimulation.  
The third aim of the project is to identify bacterial components either associated 
with live B. pseudomallei or their secreted products to modulate T cell activation. To do 
this, we used a flagellin-deficient mutant and a TTSS 3 mutant. The mechanism of this 
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Bacterial internalization and their ability to survive and replicate within host cells 
represents one facet of the pathogenic strategy of B. pseudomallei. Such a means of 
escape from host immune defenses could contribute to conditions of chronic infections 
and relapse after recovery from the clinical disease, where the dormant organism could 
become triggered from latency leading to acute disease especially in an 
immunocompromised individual (Pruksachartvuthi et al., 1990, Chaowagul et al., 1993).  
The bacterium can invade phagocytic cell lines such as mouse macrophage and 
human monocytic cell lines as well as non-phagocytic cells such as human lung epithelial 
A549 cell line (Harley et al., 1998, Jones et al., 1996, Utaisincharoen et al., 2004). 
Pathogenic mechanisms of the bacteria include escape from membrane-bound 
phagosomes into cytosol and evasion of macrophage killing by interference with 
inducible nitric oxide synthase (iNOS) production (Harley et al., 1998, Utaisincharoen et 
al., 2001). Once within the host cell, B .pseudomallei can also cause host cell death 
through a caspase-1-dependent mechanism seen in macrophages (Kespichayawattana et 
al., 2000, Sun et al., 2005).  
 Induction of pathogenic mechanisms within the very cells, such as antigen 
presenting cells (APCs) and T cells, which play an important role in driving host innate 
or adaptive immune responses, could well represent one of the most direct ways to 
subvert host immune defenses. Dendritic cells (DCs) are professional APCs that 
determine the primary activation of naïve T cells, thereby playing a pivotal role in 
initiating adaptive immunity. T cells control the adaptive immune response by acting as 
effector cells through cytotoxic activity and the production of lymphokines that further 
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help to activate innate cells like the macrophages (Schuurhuis et al., 2006, Alam and 
Gorska, 2003). Hence, by invading and causing harm to these cells, the bacterium can 
potentially disrupt both arms of host immunity. To date, little is also known about the 
pathogenic interaction between B. pseudomallei and host T cells. From previous work in 
the laboratory, it was found that B. pseudomallei also induces rapid cell death in dendritic 
cells (Sun et al., 2005).  
Therefore, we are interested in studying the interaction between the bacterium and 
host T cells and dendritic cells. We first examine the ability of the virulent B. 
pseudomallei to invade and replicate within cultured T lymphocyte and dendritic cell 
lines, as well as determine how their cell viability is affected by bacterial infection.  
 
MATERIALS AND METHODS  
Culture and maintenance of cell lines 
 
 Jurkat T cell clone E6-1(ATCC No. TIB-152) was purchased from American 
Type Culture Collection (ATCC, Manessa, VA). The mouse CD8 T cell hybridoma B3Z 
that recognizes SIINFEKL in association with H-2Kb was a kind gift from Dr. Ronald 
Germain (NIH, Bethesda, MD). DC2.4 cell line (H-2b) was a gift from Dr. Wong Siew 
Heng (Dept. of Microbology, NUS). All cells were maintained using RPMI 1640 (Sigma, 
St. Louis, MO) supplemented with 10 % Fetal Calf Serum (FCS, Hyclone Laboratories, 
Logan, UT), 200 mM L-glutamine, 100 units/ml penicillin and 100 µg/ml streptomycin 
(complete RPMI). Cells were passaged at a ratio of 1:10 every 3 to 4 days. At least 3 
hours before bacterial infection, cell culture medium was changed to 10 % FCS in the 




KHW is a virulent strain of B. pseudomallei isolated from a local patient who died 
from melioidosis (Liu et al., 2002). To prepare mid-log phase bacteria, 2 ml of Luria 
Bertani (LB) medium was inoculated with 100 µl of overnight culture and allowed to 
grow for 3 hours with constant shaking in 37 ºC incubator. All experiments involving the 
handling of live B. pseudomallei bacteria were carried out in a Class IIA biosafety 
cabinet level 2 with BSL3 safety practices in the BSL2+ pathogen-specific laboratory. 
Infection of cell lines with B. pseudomallei and intracellular bacteria replication  
 
Cells were seeded in 12-well plates in antibiotic-free RPMI medium at a density 
of 1 x 106 cells/ml. Cells were infected with B. pseudomallei strain KHW at multiplicity 
of infection (MOI) of 5:1 or 30:1. Cells were incubated with bacteria at 37°C with 5 % 
CO2. Two hours after infection, cells were centrifuged at 300 g for 5 minutes and 
supernatant was discarded. Cells were washed twice with Phosphate-buffered saline 
(PBS) and resuspended in 1 ml of fresh medium containing 250 µg/ml of kanamycin to 
suppress the growth of extracellular bacteria. Four, 8 or 24 hours after infection, cells 
were lysed with 0.1 % Triton-X-100. Serial dilutions of the lysate were plated on Tryptic 
Soy Agar (TSA) plates containing 5 µg/ml of gentamycin. Bacterial colonies on the 
plates were counted after 24 hours.  
Infection and XTT assay 
 
 Cells were seeded in a 96-well plate antibiotic-free medium at a density of 0.2 x 
106 cells/ml. Cells were infected with live bacteria at the desired MOI as described above. 
Two hours after infection, 250 µg/ml of kanamycin was added to suppress the growth of 
extracellular bacteria. Two hours after addition of kanamycin, 100 µl of XTT yellow 
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tetrazolium salt reagent (Roche Molecular Biochemicals, Germany) was added to the 
cells. Cells were incubated with XTT for 3 hours, during which viable cells will convert 
XTT to a red formazan product released into the medium with an absorbance OD490 nm 
that was measured by a spectrophotometer. In this case, the total hours of infection before 
OD490 nm is recorded are 7. For the 11 hour time point, XTT was added 4 hours after 
addition of kanamycin followed by 3 hours incubation with XTT before the OD was 
measured. XTT accumulation was determined at various time points up to 30 hours after 
infection.  
Infection and LDH assay 
 
Cells were seeded in a 96-well plate antibiotic-free medium with 2 % FCS at a 
density of 0.2 x 106 cells/ml. Cells were infected with live bacteria at the desired MOI as 
described above. Two hours after infection, 250 µg/ml of kanamycin was added to 
suppress the growth of extracellular bacteria. Four, 8 or 24 hours after infection, cell 
supernatant was collected. Lactate dehydrogenase (LDH) activity in the supernatant 
measured with Cytotoxicity Detection Kit (Roche Diagnostics, IN) according to the 
manufacturer’s instructions. Maximum release was achieved by lysing cells with 1 % 
Triton X-100. LDH activity in supernatant of uninfected cells was taken as spontaneous 
release. Percentage cytotoxicity was calculated according to this formula: % cytotoxicity 








B. pseudomallei strain KHW invasion of and intracellular replication in T and DC 
cell lines 
 
To examine the interaction of B. pseudomallei with T cells, the intracellular 
replication of the bacteria in a mouse CD8+ T cell line, B3Z T cell, was measured. Four 
hours after infection of B3Z T cells at MOI of 30 bacteria per cell, the intracellular 
bacteria count was 1.68 x 105 cfu per ml, equivalent to 1.12 % of the inoculum. After 24 
hours of infection, the number of intracellular bacteria was found to increase 
approximately 20 fold, to 3.35 x 106 cfu per ml, indicating that the bacteria were able to 
replicate within the B3Z T cells (Fig 2.1A).  
Internalization of B. pseudomallei into human Jurkat CD4+ T cells is apparently 
less efficient compared to B3Z T cells. At 4 hours after inoculation, an intracellular count 
of only 1.10 x 103 cfu per ml, correlating to 0.01 % of the inoculum, was detected in 
Jurkat T cells. However, after 24 hours of infection, the intracellular bacteria count was 
5.28 x 105 cfu per ml (Fig 2.1B). This increase in intracellular bacteria count detected at 
the later time point suggests that the bacteria, once internalized into the Jurkat T cell, can 
still survive and replicate intracellularly. The bacteria could require a longer period of 
time to adhere and enter the cells since Jurkat cells tend to clump together, thereby 
reducing the cell surface area through which the bacteria could be internalized. 
 B. pseudomallei was also able to invade the DC2.4 cells, a phagocytic dendritic 
cell (DC) line. Four hours after infection of DC2.4 cells at MOI of 5 bacteria per cell, the 
intracellular bacteria count was 4.00 x 105 cfu per ml, corresponding to 10.2 % of the 
inoculum. At 8 hours after bacterial inoculation, the intracellular number increased 
 28 
approximately 2 fold, to 8.73 x 105 cfu per ml. Being a phagocytic cell line, it is not 
surprising to observe a high rate of bacteria uptake into the DCs at early hours after 
infection. However, after 24 hours of infection, the intracellular bacteria count decreased 
to 3.58 x 105 cfu per ml (Fig 2.1C). Under the light microscope, DC2.4 cells appeared to 
be lysed by the bacteria at this time point, which could account for low intracellular 
bacteria count detected after 24 hours of infection.  
Cell Viability of B3Z T cell, Jurkat T cell and DC2.4 cell line infected with B. 
pseudomallei strain KHW 
 
Results from the LDH cytotoxicity assay indicated that DC2.4 cells have 
undergone significant cell lysis (25.5 % cytotoxicity) at 24 hours of infection (Fig 2.2). 
Thus, I compared the cell viability of B3Z T cells and Jurkat T cells with DC2.4 cells. 
When B3Z T cells were infected at MOI 5:1 and 30:1, cell viability of infected cells 
remained above 90 % and 85 % respectively from 7 to 20 hours after infection. B3Z T 
cells exhibited a significant decrease in cell viability to 28.2 % at approximately 22 hours 
after infection at MOI 30:1. At MOI 5:1, they exhibited only a gradual decrease in cell 
viability from 22 hours of infection onwards (Fig 2.3A). Of the three cell lines tested, 
Jurkat T cells were more resistant to bacteria-induced cell death. At both MOI 5:1, cell 
viability of infected Jurkat T cells remained close to 100 % from 5 to 28 hours after 
infection. At MOI 30:1, cell viability of infected cells remained above 97 % from 5 to 24 
hours after infection, and decreased to 48.5 % at 28 hours after infection (Fig 2.3B). 
Interestingly, at the earlier time point of 5 hours after infection, Jurkat cells infected at 
MOI 30:1 exhibited higher cell viability of 191.8 % relative to the uninfected T cells, 
indicated by the higher amounts of XTT conversion to formazan product by the infected 
cells compared to the uninfected cells (Fig 2.3B). This suggests that B. pseudomallei 
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could lead to T cell proliferation during early hours of infection, instead of causing early 
cell death as in dendritic cells. This result could not be a false positive as there was no 
significant conversion of XTT reagent to formazan product by B. pseudomallei cultured 
alone, in the absence of T cells (data not shown).  
In comparison to the T cell lines tested, B. pseudomallei infection causes rapid 
cell death in DC2.4 cell line. At both MOI 5:1 and 30:1, cell viability of DC2.4 cells was 
81.8 % and 73.4 % respectively at 7 hours after bacterial infection and continued to 
decrease over time to only 15.1 % and 9.3 % respectively at 15 hours after infection (Fig 
2.3C). The above results show that non-phagocytic T cells are less susceptible to a 
bacteria-induced cell death as compared to the phagocytic DCs, which could be 






























































































































Figure 2.1 Invasion and replication of B. pseudomallei in cell lines 
 
1 x 106 B3Z T cells (A), Jurkat T cells (B) and DC2.4 (C) cells were infected with B. 
pseudomallei strain KHW at an MOI of approximately 30:1 (B3Z and Jurkat T cells) and 
5:1 (DC2.4 cells). 4, 8 and 24 hours after infection, the intracellular bacterial cfu count 
was determined. The experiment was repeated at least three times and error bars represent 
























Figure 2.2 Percent cytotoxicity of DC2.4 cells after infection with B. pseudomallei 
0.2 x 106 DC2.4 cells were infected with B. pseudomallei strain KHW at an MOI of 
approximately 5:1. At various time points after bacterial infection, the amount of LDH in 
the cell supernatant was measured. LDH activity of the uninfected cells was taken as the 
spontaneous release and % cytotoxicity of infected cells was calculated as described in 
Materials and Methods. The experiment was repeated at least three times and error bars 
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Figure 2.3 Percent cell viability of B3Z T cells, Jurkat T cells and DC2.4 cells after 
infection with B. pseudomallei 
 
0.2 x 106 B3Z T cells (A), Jurkat T cells (B) and DC2.4 cells (C) were infected with B. 
pseudomallei strain KHW at an MOI of approximately 5:1 (dashed line) and 30:1 (solid 
line). At various time points after bacterial infection, the amount of XTT conversion by 
the cells was determined by measuring OD490 nm of the red formazan product. Percent 
cell viability of the bacteria-infected cells was calculated relative to the uninfected cells 
as a control with 100% cell viability. The experiment was repeated at least three times 







 It is evident that B. pseudomallei can invade, survive and multiply within both 
phagocytic cells including macrophages and monocytes as well as non-phagocytic cell 
lines such as human lung epithelial cells. This could account for the occurrence of latent 
infections and disease relapse from reactivation of the bacterium persisting within the 
host (Harley et al., 1998, Jones et al., 1996). Results of our study have shown that the 
above list can be expanded to include murine phagocytic dendritic cells and also non-
phagocytic T cells of mouse or human origin. To date, there have been no published 
reports on intracellular replication of B. pseudomallei in T cell lines.  
The interaction of B. pseudomallei with mouse and human T cells provides a 
means to study how the bacterium can directly disrupt the adaptive arm of host immunity. 
In our study, we found that internalization and intracellular replication of virulent B. 
pseudomallei KHW strain could occur in human Jurkat T cells and mouse B3Z T cells, 
both being non-phagocytic cells. T cells are central players that control the adaptive 
immune responses. Therefore, the entry and persistence of the pathogen within these cells 
could potentially affect their functions by inhibiting cellular signaling pathways or 
directly decreasing their viability. B. pseudomallei infection was found to result in 
significant decrease in B3Z T cell and Jurkat T cell viability at around 22 and 28 hours 
after infection. When the bacteria eventually cause death of the infected T cells, the host 
could then be unable to mount an adequate adaptive immune response. During an 
intracellular bacterial infection, antibody responses provide protection before the bacteria 
become internalized and reside within the host cells. In this case, the eradication of the 
pathogen would largely rely on the antigen-specific effector T cells that can cause 
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cytotoxicity of infected cells or release cytokines that help to further activate the infected 
macrophages. CD4+ helper T cells secrete cytokines required for activation of 
macrophages and for antibody responses (Raupach and Kaufmann, 2001, Alam and 
Gorska, 2003). Macrophages are important phagocytic antigen-presenting cells (APCs) of 
the innate immune system, which are capable of engulfing bacteria and killing through 
phagosomal acidification and production of reactive oxygen intermediates (Kaufmann, 
1993). Hence, by causing T cell death, B. pseudomallei can also indirectly affect host 
innate immunity. 
B. pseudomallei internalization into Jurkat T cells was observed to be less 
efficient compared to B3Z T cells, with close to 0 % of the inoculum detected in the 
former at 4 hours after infection.  However, the numbers of intracellular bacteria 
increased at later time points after infection, indicating that the bacterium was still 
capable of entering and replicating within the human T cells. Internalization and 
intracellular replication of B. pseudomallei was also observed in dendritic cells (DCs). 
10.2 % of the bacterial inoculum was detected in these cells at 4 hours after infection, 
corresponding to the highest rate of bacteria uptake in comparison to the other two T cell 
lines tested. This observation is not unforeseen since DCs are professional APCs that are 
phagocytic in nature. In this context, host APCs retain their ability to phagocytose 
extracellular pathogenic organisms, and bacterial antigens are expected to become 
processed and presented to naïve T cells. However, although the bacteria could be 
phagocytosed by DCs, this facet of the innate immune response is still botched by the 
bacteria-induced rapid cell death seen in the infected DCs. Cell viability of infected DCs 
started to decline rapidly from as early as 7 hours after infection.  
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DCs are professional APCs which capture the bacteria for digestion within the 
phagosomes. The released immunogenic antigens are processed to peptides being 
complexed with MHC molecules and then presented to naïve T cells. The latter requires 
antigen recognition by T cell receptor and a second coactivation signal provided by 
surface costimulatory ligands e.g. CD80/ CD86 found on the DCs to achieve full 
activation (Jenkins and Johnson, 1993). Hence, DC-T cell interaction is important for 
controlling the development of T cell responses in protective immunity. A recent study 
reported that immunization with DCs that were pulsed with heat-killed B. pseudomallei 
strain K96243 generated strong protective immune responses in mice (Elvin et al., 2006). 
By causing early death of the host DCs, B. pseudomallei could destroy this pivotal link 
between the innate and adaptive arm of immunity. Rapid cell death of DCs caused by B. 
pseudomallei is supported by previous data demonstrating bacteria-induced early cell 
death in human DCs (Sun et al., 2005). 
By entering and residing in DCs as well as T cells, the bacterium could hide itself 
from the host humoral response. At the same time, the intracellular pathogen can induce 
death of these cells, hence destroying the essential cellular players that control the 
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During initial stages of bacterial infection, innate immune responses are important 
to control the pathogen. Innate immune cells such as macrophages, natural killer (NK) 
cells and neutrophils recognize pathogen-associated molecular patterns (PAMPs) 
expressed on the bacteria through pattern recognition receptors (PRR) such as Toll-like 
receptors (TLR), scavenger receptors and mannan-binding lectins to become activated to 
kill. However, B. pseudomallei have developed various mechanisms to evade host innate 
immune responses. Studies have shown that the bacterium can interfere with phagocytic 
cell functions and resist killing within these phagocytes (Dorman et al., 1998, Egan and 
Gordon, 1996, Renella et al., 2006). Such pathogenic interference could result in 
persistence of the bacteria within the host. At such a juncture when innate immunity is 
breached, CMI responses could be important to control the infection. 
In intracellular bacterial infections caused by Salmonella and mycobacterial  
species, T cells are also known to play a pivotal role in CMI responses. Being a 
facultative intracellular pathogen, B. pseudomallei can similarly invade and reside within 
host cells. T cell-mediated responses are particularly essential since antibodies specific to 
the bacterium have little protective effect once the pathogen remains intracellular (Ho et 
al., 1997, Raupach and Kaufmann, 2001). It is important for the infected host cells to 
interact with antigen-specific T cells, to trigger T cell proliferation, clonal expansion and 
differentiation into effector T cells (Alam and Gorska, 2003). The latter includes 
cytotoxic CD8+ T cells that can induce lysis of infected host cells and CD4+ helper T cells 
that secrete cytokines, which are soluble intercellular messenger molecules, each of them 
having specific effects on the target cells. For example, IFN-γ is important for 
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macrophage activation while IL-2 and IL-4 promote B cell proliferation and 
differentiation (Andersen et al., 2006). T cells thus play an important role in orchestrating 
appropriate host CMI responses.  
There are recent reports supporting the importance of CMI responses for 
protection against progression in melioidosis. One study reported that T lymphocytes 
taken from patients who recovered from melioidosis showed enhanced proliferation and 
IFN-γ production in response to B. pseudomallei antigens (Ketheesan et al., 2002). The 
pro-inflammatory cytokine IFN-γ is important for early host resistance against B. 
pseudomallei infection (Santanirand et al., 1999). In addition, asymptomatic individuals 
who are seropositive demonstrate stronger CMI responses as reflected by enhanced 
proliferation of their lymphocytes in response to B. pseudomallei antigens when 
compared to individuals who had clinical symptoms of infection (Barnes et al., 2004). 
These reports provide evidence suggesting that a strong CMI response could be important 
for protection against disease progression, where those who fail to mount an adequate 
CMI response could succumb to clinical infection. A recent study has also shown that T 
cells contribute to host resistance during later stages of B. pseudomallei infection, 
whereby CD4+ T cells could be primarily involved in protection since CD4+ T cell-
depleted mice showed shorter mean survival time after infection (Haque et al., 2006). B. 
pseudomallei could also prime both antigen-specific CD4+ and CD8+ T cells, reflected 
from enhanced IFN-γ production in response to heat killed bacteria by these cells taken 
from infected mice (Haque et al., 2006). 
Although some information is available on how B. pseudomallei can compromise 
innate immunity, for example by affecting phagocytic cell function, there have not been 
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similar reports on T cell responses. In the case of Yersinia infection, T cell responses are 
critical to the host survival. However, Yersinia have the ability to directly suppress T cell 
activation through the virulence factor YopH, a tyrosine phosphatase, which binds to and 
inhibits signaling intermediates crucial for T cell antigen receptor (TCR) signaling such 
as linker for activation of T cells (LAT) and SH2-domain-containing leukocyte protein of 
76 kD (SLP-76) (Alonso et al., 2004, Gerke et al., 2005). This is an example of a 
mechanism by which pathogens could alter T cell-mediated immune responses by 
crippling T cell signaling.  
To date, not much is known about the interaction of B. pseudomallei and T cell-
mediated immunity. We have shown in the previous chapter that the bacterium can 
invade and replicate within human Jurkat and mouse B3Z T cell lines. The bacterium did 
not induce rapid cell death in T cells as seen in dendritic cells. Hence, we are interested in 
studying how B. pseudomallei infection could affect host T cell function before 
eventually causing death of the infected cells. To do this, we test if human Jurkat CD4+ T 
cells and mouse B3Z CD8+ T cells that are infected with virulent B. pseudomallei strain 
KHW show any altered response to T cell receptor (TCR) stimulation by measuring 
Interleukin-2 (IL-2) production by the infected cells upon engaging their TCR.  
To correlate the observed effects of B. pseudomallei infection on IL-2 production 
by T cells to the presence of certain bacterial virulence factors, cells were also tested with 
bsaQ and fliC mutants. The bsaQ mutant does not have the bsaQ gene that encodes a 
conserved structural component of the TTSS and the fliC mutant is an isogenic fliC gene 
deletion mutant of B. pseudomallei strain KHW. Effects of the mutants on IL-2 
production of infected T cells were compared to that of wild type. 
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MATERIALS AND METHODS 
Culture and maintenance of cell lines 
 
Jurkat T cell clone E6-1 and B3Z T cell line were cultured and maintained as 
described in Chapter 2 Materials and Methods section.  
Bacterial strains 
KHW is a virulent strain of B. pseudomallei isolated from a local patient who died 
from melioidosis (Liu et al., 2002). bsaQ, a B. pseudomallei mutant with loss of bsaQ 
gene was constructed by insertional mutagenesis from strain KHW (Sun et al., 2005). 
KHWFliCKO is an isogenic FliC/ flagellin deletion mutant of B. pseudomallei by 
targeted gene replacement via homologous recombination (Chua et al., 2003). WT E. coli 
bacteria used was E. coli strain M15. E. coliFliCKO was a kind gift from Dr. Nancy 
Kleckner (Department of Molecular and Cellular Biology, Harvard University, 
Cambridge) (Bates et al., 2005). B. thailendensis (ATCC No. 700388), an avirulent 
species closely related to B. pseudomallei, was purchased from ATCC. To prepare mid-
log phase bacteria, 2 ml of Luria Bertani (LB) medium was inoculated with 100 µl of 
overnight culture and allowed to grow for 3 hours with constant shaking in 37ºC 
incubator. KHWFliCKO was cultured in LB medium containing 50 µg/ml of kanamycin 
since the mutant carried a kanamycin resistant cassette inserted into the gene encoding 
for fliC protein, a monomer making up bacterial flagella. 
Infection of T cells with live bacteria strains 
 
Cells were seeded in 12-well plates in antibiotic-free medium at a density of 2 x 
106 cells/ ml at least 3 hours before infection. Cells were inoculated with B. pseudomallei 
KHW, bsaQ, KHWFliCKO, B. thailandensis, E. coli strain M15 or E. coliFliCKO at MOI 
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of approximately 30 colony forming unit (cfu) per cell. Bacteria for inoculation was 
prepared from mid log phase bacteria culture by resuspending a bacteria pellet 
approximated to 60 cfu in 100 µl of fresh LB, which was added to the cells. Plates were 
subsequently centrifuged at 600 g for 10 minutes prior to incubation at 37°C with 5% 
CO2 for 2 hours.  
Costimulation of bacteria-infected T cells with TCR stimulus 
Two hours after infection, cells were centrifuged at 300 g for 5 minutes and 
supernatant was discarded. Cells were washed twice with PBS and resuspended in 1 ml 
of RPMI containing 40 µg/ml of tetracycline to suppress the growth of extracellular 
bacteria (100 µg/ml streptomycin was also used for E. coli infection). 0.2 x 106 cells were 
transferred to 96-well plates previously coated with 2.5 µg/ml of anti-CD3 monoclonal 
antibody (mAb) (BD Pharmingen, San Diego, CA) per well. Infected cells were 
incubated with surface-bound anti-CD3 mAb, in medium containing 40 µg/ml of 
tetracycline, at 37°C with 5% CO2 for 22 hours (Jurkat T cells) or 20 hours (B3Z T cells). 
Cell supernatant was collected and IL-2 levels were determined using ELISA.  
Costimulation of T cells with bacteria culture supernatant and TCR stimulus 
Mid-log phase bacteria were prepared by inoculating 100 µl of overnight bacteria 
culture in 2 ml LB and allowed to grow for 3 hours with constant shaking in 37ºC 
incubator. KHWFliCKO was cultured in LB medium containing 50 µg/ml of kanamycin. 
The log phase subculture was centrifuged at 4000 g for 10 min to pellet down the 
bacteria. Supernatant was removed and passed through a 0.22 micron membrane syringe 
filter to remove any remaining bacteria. Jurkat T cells were seeded in 12-well plates in 
antibiotic-free medium at a density of 2 x 106 cells/ml. 200 µl of supernatant was added 
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to the cells prior to incubation at 37°C with 5% CO2. Two hours later, cells were 
centrifuged and washed with PBS followed by costimulation with anti-CD3 mAbs 
according to the protocol described above. Cell supernatant was collected and IL-2 levels 
were assayed. Proteinase K-treated supernatant was prepared by incubating 200 µl of 
filtered bacteria supernatant 1 µg/ml pf proteinase K for 1 hour at 37°C, followed by 
incubation for 45 min at 80°C to inactivate proteinase K. Heat-treated supernatant was 
prepared by boiling 200 µl of supernatant in a boiling water bath for 10 minutes. 
Costimulation of T cells with heat-killed bacteria and TCR stimulus 
Heat-killed bacteria were prepared by heating mid log phase bacteria resuspended 
in PBS in a 90°C for 1 hour. Jurkat T cells were seeded in 12-well plates in antibiotic-
free medium at a density of 2 x 106 cells/ml. Heat-killed bacteria were added to the cells 
at a bacteria-cell ratio of 5:1, 30:1 or 100:1 prior to incubation at 37°C with 5% CO2. 
Two hours later, cells were centrifuged and washed with PBS followed by costimulation 
with anti-CD3 mAbs according to the protocol described above. Cell supernatant was 
collected and IL-2 levels were determined using ELISA.  
Protein precipitation using trichloroacetic acid (TCA)  
5-10 ml of mid-log phase bacteria culture were centrifuged at 4000 g for 5 min. 
Supernatant was filtered through a 0.22 micron syringe filter. In a 1.5 ml microfuge tube, 
1 volume of 100 % TCA was added to 4 volumes of supernatant followed by spinning at 
14,000 rpm for 5 min. Supernatant was carefully removed leaving the protein pellet 
intact. 1 ml of cold acetone was added to the pellet and samples were centrifuged at 
14,000 rpm for 5 min. Two more acetone washes were performed and the protein pellet 
was dried by placing tube in 95°C heat block for 5-10 min to drive off the acetone. 
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Immunodetecion of flagellin by Western Blotting 
Protein pellet prepared by TCA precipitation was dissolved in sodium dodecyl 
sulfate-polyacrylamide (SDS) loading dye containing βmercaptoethanol, boiled for 10 
minutes in a boiling water bath and run on a SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) gel with 4 % and 10 % polyacrylamide stacking and resolving gel 
respectively followed by electroblotting onto nitrocellulose membrane. Western blot 
hybridization was performed using 20 mM Tris-HCl (pH 7.5) with 500 mM NaCl and 
0.05 % Tween (TBS-T) containing 5 % bovine serum albumin (Sigma) as the blocking 
reagent. 1:100 dilution of mouse polyclonal anti-flagellin antibodies was used as the 
primary antibody. Mouse serum containing anti-flagellin antibodies was obtained from 
intra-peritoneal immunization of mice with recombinant FliC protein prepared by Ng H. 
L in the laboratory. After 1 hour incubation with primary antibody, the membrane was 
washed three times with TBS-T and incubated with 1:10000 dilution of horseradish 
peroxidase-conjugated goat anti-mouse Immunoglobulin G (Amersham, UK) for 1 hour. 
The membrane was washed 3 times and immersed in Enhanced chemiluminescence 
(ECL) detection reagent (Amersham) for the detection of bound HRP-conjugated 
secondary antibody by autoradiography. 
Antigenic stimulation of bacteria-infected B3Z T cells with OVA peptide 
 
DC2.4 cells were seeded at a density of 5 x 104 cells/ml in a 96-well plate in 
complete medium. Cells were fixed for 20 minutes with 1 % formaldehyde. Cells were 
washed 2 times with PBS and pulsed with 200 pg/ml of SIINFEKL OVA peptide for 1 
hour. B3Z T cells were infected with bacteria for 2 hours at various MOIs according to 
the procedure described above and 5 x 104 cells were transferred to 96-well containing 
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pulsed DC2.4 cells. 18 hours later, cell supernatant was collected and IL-2 levels were 
determined by ELISA. 
Cytokine ELISA 
 
At various time points indicated, cell supernatant was harvested and production of 
IL-2 cytokine by infected Jurkat and B3Z T cells upon TCR engagement was measured 




























Enhanced IL-2 production by Jurkat T cells infected with live B. pseudomallei  
 
Jurkat T cell clone E6-1 is a human leukemic T cell line known to produce large 
amounts of IL-2 cytokine after stimulation (Weiss et al., 1984). Furthermore, much in 
vitro work to elucidate important T cell signaling pathways, for example TCR-mediated 
signaling, have been largely based on using Jurkat T cell line as a study model (Abraham 
and Weiss, 2004).  Hence, Jurkat T cells were chosen as the cell line to study the effects 
of B. pseudomallei infection on T cell cytokine production upon TCR engagement.  
Jurkat T cells that were infected with B. pseudomallei strain KHW at MOI 1:1, 
MOI 5:1 and MOI 30:1 for two hours, followed by exposure to TCR stimulus supplied in 
the form of surface-coated anti-CD3 mAbs, produced 1.7, 2.2 and 4.0 fold greater IL-2 
amounts respectively as compared to uninfected cells (Fig 3.1A). Our laboratory has 
previously shown the inability of bsaQ mutant to induce lysis of THP-1 cells (Sun G. W. 
et al, 2005). Jurkat T cells that were infected with bsaQ at MOI 30:1 similarly exhibited 
4.1 fold increase in IL-2 production compared to uninfected cells upon TCR engagement 
(Fig 3.1B). Cells that were incubated with B. thailandensis at MOI 30:1, a closely related 
avirulent species of Burkholderia, were found to produce 7.0 fold higher IL-2 levels than 
uninfected cells (Fig 3.1B). In all cases, cells were incubated with bacteria for 2 hours 
followed by 22 hour incubation with anti-CD3 mAb, resulting in a total 24-hour period of 
infection, after which time, cell supernatant was harvested and assayed for IL-2. 
Throughout this period, cells were still viable as supported by previous data showing that 
cell viability of infected Jurkat T cells decreased only at 28 hours after infection. It is thus 
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evident from the results that bacterial interaction with host T cells seems to provide a 
coactivation signal that is manifested in their increased IL-2 cytokine production.  
Enhanced IL-2 production by Jurkat T cells interacting with live B. pseudomallei in 
the absence of direct cell-bacteria contact 
 
 B. pseudomallei were previously found to invade Jurkat T cells with poor 
efficiency where only 0.01 % of the inoculum was found in host cells after 4 hours of 
infection. We hypothesize that bacterial modulation of host T cell cytokine production 
may not be solely dependent on bacterial entry into cells. Jurkat T cells were incubated 
for 2 hours with live B. pseudomallei strain KHW added into a transwell with a 0.4 
micron membrane pore size to prevent cell-bacteria contact and subsequently exposed to 
surface-bound anti-CD3 mAb for 22 hours. The cells were found to produce 2.0 fold 
higher amounts of IL-2 compared to uninfected cells (Fig 3.2), indicating that the bacteria 
could be secreting a soluble costimulatory factor that can pass through the transwell 
membrane to contact the cells. To ensure that bacteria in the transwell had not passed 
through the membrane to contact the cells in the bottom well, the latter were observed 
with the light microscope under high magnification to check for the absence of bacteria 
swimming among the cells in the medium. Infection of T cells with live B. pseudomallei 
in the absence of a transwell separation, where bacteria can contact the cells, resulted in a 
3.3 fold enhancement of IL-2 production (Fig 3.2).  
To further test the hypothesis that B. pseudomallei strain KHW could be secreting 
a costimulatory factor, cells were treated with bacterial culture supernatant harvested 
from log phase bacterial culture for 2 hours, followed by exposure to anti-CD3 mAb. 
Cells treated with bacterial supernatant similarly showed a 1.9 fold increase in IL-2 
production compared to untreated cells (Fig 3.3). Bacterial culture supernatant was 
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filtered before addition to the cells to ensure the absence of live bacteria that would 
otherwise directly contribute to T cell costimulation. Incubation of cells with live B. 
pseudomallei resulted in a 4.5 fold increase in IL-2 production (Fig 3.3). In the positive 
control, cells were costimulated with soluble anti-CD28 mAb and found to exhibit a 
similar fold enhancement (4.6 fold) in IL-2 production as when the cells were 
costimulated by live bacteria (Fig 3.3). It is known that CD28-mediated T cell 
costimulation is an important coactivation signal provided by CD80/ CD86 ligands on 
antigen-presenting cells to enable full activation of naïve T cells (Jenkins and Johnson, 
1993).  
Infection with live bacteria resulted in greater enhancement of IL-2 production as 
compared to incubation with bacteria in a transwell set up or with bacterial supernatant. 
This suggests that bacterial coactivation of host T cells is potentially more potent in the 
event when bacteria are allowed to contact the cells while at the same time, a stimulatory 
bacterial factor is also released by the bacteria onto the cells. 
Bacterial culture supernatant pre-treated with proteinase K showed a significantly 
reduced enhancement (1.2 fold) of IL-2 production by Jurkat T cells compared to 
untreated bacterial supernatant that resulted in 1.7 fold increase in IL-2 production (Fig 
3.4). However, heat-treated bacterial supernatant was able to enhance IL-2 production to 
a similar extent as untreated bacterial supernatant (Fig 3.4). This suggests that the 
costimulatory component found in B. pseudomallei supernatant could be a protein. In 
addition, heat denaturation could not disrupt the availability of this protein’s epitope for 
recognition by costimulatory receptors on the T cells. 
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Absence of costimulatory effect of heat-killed B. pseudomallei on IL-2 production by 
Jurkat T cells 
 
 When Jurkat cells were incubated with heat-killed B. pseudomallei strain KHW at 
bacteria-cell ratios of 5:1 and 30:1, there was no enhancement IL-2 production from the 
low basal levels of IL-2 produced by untreated cells. Incubation of T cells with heat-
killed bacteria alone did not result in any IL-2 production (Fig 3.5). This shows that 
costimulatory properties of B. pseudomallei could either be due to the presence of heat-
labile bacterial components or is essentially dependent on the bacteria being alive and 
hence able to secrete costimulatory components or interact with host T cells. 
Comparison of IL-2 production by Jurkat T cells infected with live WT B. 
pseudomallei strain KHW or KHWFliCKO live bacteria and culture supernatant   
 
B. pseudomallei is motile due to the presence of flagella, filamentous appendages 
required for bacterial chemotaxis and motility, which are also virulence determinants of 
the pathogen (Chua et al., 2003). Flagella are composed of a structural repeating protein 
monomer called flagellin (FliC). FliC is a known ligand for TLR5 that has been shown to 
have direct costimulatory effects on human CD4+ T cell proliferation and cytokine 
production (Lino, 1977, Caron et al., 2005). To determine if B. pseudomallei modulation 
of host T cell IL-2 production can be correlated to the presence of flagella on the bacteria, 
we tested the T cell costimulatory effects of KHWFliCKO. We observed that wild type 
(WT) B. pseudomallei strain KHW had greater costimulatory effects on Jurkat T cell 
cytokine production than KHWFliCKO. Cells that were infected with WT KHW produced 
9.2 fold higher amounts of IL-2 upon TCR engagement than uninfected cells. On the 
other hand, infection with KHWFliCKO resulted in a 4.9 fold increase in IL-2 production 
upon TCR stimulation (Fig 3.6). Since KHWFliCKO mutant was aflagellate and non-
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motile in semisolid agar, upon inoculation of WT or mutant bacteria, the plate was 
centrifuged at 600g for 10 minutes to facilitate bacteria-cell contact within the well (Chua 
et al., 2003). In an unpublished data in our laboratory, infection with KHWFliCKO 
together with the centrifugation procedure resulted in similar percent cell death as WT 
KHW in human macrophages. Hence, this procedure has been shown to be able 
effectively facilitate bacteria-host cell contact. Therefore, the partial reduction in IL-2 
response of cells to costimulation by KHWFliCKO bacteria could not be a result of the 
reduced ability of the non-motile mutant bacteria to contact or invade the cells. The 
above results suggest that costimulatory effects of live B. pseudomallei is only partially 
due to the presence of FliC protein since fliC deletion mutant was still able to costimulate 
T cells to augment their cytokine production, though to a lower extent when compared to 
costimulation by WT KHW. This indicates the presence of other costimulatory bacterial 
components in B. pseudomallei that are responsible for augmenting T cell cytokine 
production. 
The flagellae of many motile bacteria e.g. Salmonella, are comprised of the basal 
body, the hook, and the filament that is composed mainly of the protein FliC (Macnab, 
2004). The secretion of flagellin monomer for the assembly of flagellae in Salmonella is 
similar to the secretion of virulence factors and requires an export machinery across both 
inner and outer bacterial cell membranes (Macnab, 1999, Galan and Collmer et al., 1999). 
Flagellin is normally found in abundance in S. typhimurium supernatants and is easily 
detected by immunoblot. In order to determine if flagellin was a T cell costimulatory 
component released by the bacteria, supernatants from the WT B. pseudomallei strain 
KHW or KHWFliCKO bacteria culture used for the above cell infection were also 
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harvested, filtered and separately incubated with the cells for 2 hours, followed by 
subsequent exposure to anti-CD3 mAb. WT KHW supernatant resulted in a 4.9 fold 
increase in IL-2 production compared to untreated cells. However, no significant increase 
in IL-2 production was detected when cells were treated with KHWFliCKO supernatant 
(Fig 3.6). This indicates that flagellin could be the costimulatory factor in the WT 
bacterial supernatant. To confirm the presence of flagellin in the WT supernatant, protein 
was precipitated from filtered WT KHW and KHWFliCKO culture supernatant and 
subjected to immunodetection by Western blotting using mouse polyclonal anti-FliC 
antibodies. Flagellin was detected in WT KHW supernatant but not at all in KHWFliCKO 
supernatant (Fig 3.7). Altogether, the results indicate that, in contrast to that of live 
bacteria, the costimulatory effects of bacterial supernatant could be predominantly 
attributed to FliC protein secreted by the bacteria into the culture, the absence of which 
could almost completely abolish the costimulatory activity of B. pseudomallei culture 
supernatant.  
The experiment was repeated with WT E. coli and fliC deletion E. coli mutant 
bacteria and bacterial supernatants. Jurkat T cells that were infected with WT E. coli 
produced 3.4 fold higher amounts of IL-2 upon TCR engagement than uninfected cells. 
However, infection with E. coliFliCKO did not result in any enhancement of IL-2 
production compared to uninfected cells (Fig. 3.8). Likewise, WT E. coli supernatant 
resulted in a 2.5 fold increase in IL-2 production while E. coliFliCKO supernatant did not 
result in an increase in IL-2 production compared to untreated cells (Fig. 3.8). This 
indicates that similar to B. pseudomallei, flagellin could be the costimulatory factor 
present in E .coli supernatant. However, E. coliFliCKO bacteria, unlike KHWFliCKO, 
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did not appear to exhibit any costimulatory properties. This suggests that flagellin could 
likely be the main costimulatory component associated with live E. coli, while 
costimulatory components other than flagellin are involved in the case of live B. 
pseudomallei. 
Enhanced IL-2 production by purified human CD4+ T cells infected with live B. 
pseudomallei  
 
 Previous observations of B. pseudomallei modulation of IL-2 production were 
seen in Jurkat T cells, a transformed leukemic T cell line. To determine the physiological 
relevance of T cell costimulatory effects of B. pseudomallei previously observed in Jurkat 
cells, we tested the effects of live B. pseudomallei infection on IL-2 production by 
primary human CD4+ T cells, purified from human peripheral blood mononuclear cells 
(PBMCs). When these cells were infected for 2 hours with B. pseudomallei KHW at MOI 
30:1 and exposed to anti-CD3 mAb, they produced higher levels of IL-2 detected in cell 
supernatant after 24 hours, as compared to uninfected CD4+ T cells. Infection with 
KHWFliCKO bacteria resulted in low IL-2 levels, similar to that of uninfected T cells 
(Fig 3.9).  In comparison to Jurkat T cell lines, primary human T cells require a longer 
period of incubation of 30 hours or more with anti-CD3 mAb to produce detectable IL-2 
levels (Fig 4.7). In this study, human CD4+ T cells were infected for 2 hours and 
incubated with TCR stimulus for only 22 hours, hence only very low amounts of IL-2 
could be detected in the event of costimulation. The total time period of bacterial 
infection was limited to 24 hours, since the cytotoxic effects of live B. pseudomallei on 
human T cells have not been tested and long hours of infection could affect cell viability. 
Nonetheless, it is evident from the above results that costimulatory effects of WT B. 
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pseudomallei strain KHW is also seen for human CD4+ T cells, supporting the 


















































































Figure 3.1 IL-2 production by Jurkat T cells infected with B. pseudomallei strain 
KHW, bsaQ mutant and B. thailandensis after exposure to TCR stimuli 
 
Jurkat T cells were infected with B. pseudomallei strain KHW at an MOI of 
approximately 1:1, 5:1 or 30:1 (A) or with strain KHW, bsaQ mutant and B.  
thailandensis at MOI 30:1 (B) for 2 hours followed by 22 hour exposure to 2.5 µg/ml of 
surface-bound anti-CD3 mAb (TCR stimulation). IL-2 concentrations in the cell 
supernatants were determined by ELISA. In the absence of anti-CD3 stimulation, there 
was no detectable IL-2 secretion by T cells with or without bacterial infection (data not 
plotted). The experiment was repeated at least three times and error bars represent the 





































Figure 3.2 IL-2 production by Jurkat T cells incubated with B. pseudomallei strain 
KHW in a trans-well set up to exclude direct cell-bacteria contact 
 
Jurkat T cells were incubated with B. pseudomallei strain KHW at an MOI of 
approximately 30:1 in the presence (KHW) or absence of bacteria-cell contact (KHW 
transwell) by adding the bacteria into a 0.4-micron membrane transwell placed within a 
24-well containing the cells. Two hours later, the cells were incubated with 2.5 µg/ml of 
surface-bound anti-CD3 mAb (TCR stimulation) for 22 hours before IL-2 levels in the 
cell supernatants were determined by ELISA. In the absence of anti-CD3 stimulation, 
there was no detectable IL-2 secretion by T cells with or without bacterial infection (data 
not plotted). The experiment was repeated at least three times and error bars represent the 















































Figure 3.3 IL-2 production by Jurkat T cells treated with B. pseudomallei strain 
KHW bacterial culture supernatant  
 
Jurkat T cells were incubated for 2 hours with live B. pseudomallei KHW at an MOI of 
approximately 30:1 (KHW) or log phase bacterial culture supernatant filtered through a 
0.2 micron membrane (KHW Sup). Cells were then stimulated with 2.5 µg/ml of surface-
coated anti-CD3 mAb for 22 hours. For the positive control, uninfected cells were 
incubated with anti-CD3 mAb together with 0.5 µg/ml of soluble anti-CD28 mAb. IL-2 
levels in the cell supernatants were determined by ELISA. In the absence of anti-CD3 
stimulation, there was no detectable IL-2 secretion by T cells with or without bacterial 
infection (data not plotted). The experiment was repeated at least three times and error 
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Figure 3.4 IL-2 production by Jurkat T cells treated with KHW bacterial culture 
supernatant  
 
Jurkat T cells were incubated for 2 hours with log phase KHW Supernatant (KHW Sup), 
KHW supernantant pre-treated with 1 µg/ml proteinase K (Proteinase K-treated KHW 
Sup) or heat-treated KHW supernantant (Boiled KHW Sup). All bacterial supernatant was 
filtered through a 0.2 micron membrane. Cells were then stimulated with 2.5 µg/ml of 
surface-coated anti-CD3 mAb for 22 hours. IL-2 levels in the cell supernatants were 
determined by ELISA. In the absence of anti-CD3 stimulation, there was no detectable 
IL-2 secretion by T cells with or without treatment with the different bacterial 
supernatants (data not plotted). The experiment was repeated at least three times and error 
















































Figure 3.5 IL-2 production by Jurkat T cells treated with heat-killed B. pseudomallei 
strain KHW 
 
Jurkat T cells were incubated with heat-treated B. pseudomallei strain KHW at bacteria-
cell ratios of 5:1, 30:1 or 100:1 for 2 hours, followed by stimulation with 2.5 µg/ml of 
surface-bound anti-CD3 mAbs for 22 hours. IL-2 levels in the cell supernatants were 
determined by ELISA. IL-2 was not detected when cells were incubated with heat-killed 
bacteria alone (HK KHW 100:1 alone) and basal IL-2 levels were detected when 
untreated cells were stimulated with anti-CD3 mAbs (aCD3 alone). In the absence of 
anti-CD3 stimulation, there was no detectable IL-2 secretion by T cells with or without 
treatment heat-killed bacteria supernatant (data not plotted). The experiment was repeated 












































Figure 3.6 IL-2 production by Jurkat T cells infected with WT B. pseudomallei 
strain KHW or KHWFliCKO live bacteria and bacterial culture supernatant  
 
Jurkat T cells were infected with live B. pseudomallei strain KHW or KHWFliCKO 
bacteria at an MOI of approximately 30:1. Supernatant from the same log phase WT 
(KHW supernatant) or FliC mutant (KHWFliCKO supernatant) bacterial culture that was 
used for infection was collected and filtered through a 0.22-micron membrane. Cells were 
incubated with live bacteria or supernatants for 2 hours before stimulation with 2.5 µg/ml 
of surface-coated anti-CD3 mAb for 22 hours. IL-2 levels in the cell supernatants were 
determined by ELISA. In the absence of anti-CD3 stimulation, there was no detectable 
IL-2 secretion by T cells with or without bacterial infection or treatment with bacteria 
supernatant (data not plotted). The experiment was repeated at least three times and error 





































































Figure 3.7 Detection of FliC protein in B. pseudomallei strain KHW culture 
supernatant by Western blot 
 
Western blot analysis of flagellin protein, FliC, in protein precipitates prepared from 
bacteria-free WT KHW (Lane 1) or KHWFliCKO (Lane 2) bacterial supernatant. 
Approximately 5 µg portions of protein were separated on a SDS-10% polyacylamide gel 
and immunoblotted with polyclonal mouse anti-flagellin antibodies. Lane 3 contained 1 
µg of recombinant B. pseudomallei FliC protein. The bands on the gel correspond to the 


















































Figure 3.8 IL-2 production by Jurkat T cells infected with WT E. coli or E. 
coliFliCKO live bacteria and bacterial culture supernatant  
 
Jurkat T cells were infected with live WT E. coli or E.coliFliCKO bacteria at an MOI of 
approximately 30:1. Supernatant from the same log phase WT (WT E.coli Sup) or fliC 
mutant (E.coliFliCKO Sup) bacterial culture that was used for infection was collected 
and filtered through a 0.22-micron membrane. Cells were incubated with live bacteria or 
supernatants for 2 hours before stimulation with 2.5 µg/ml of surface-coated anti-CD3 
mAb for 22 hours. IL-2 levels in the cell supernatant were determined by ELISA. In the 
absence of anti-CD3 stimulation, there was no detectable IL-2 secretion by T cells with 
or without bacterial infection or treatment with bacteria supernatant (data not plotted). 
The experiment was repeated at least two times and error bars represent the standard 












































Figure 3.9 IL-2 production by purified human CD4+ T cells infected with live B. 
pseudomallei KHW 
 
Primary human CD4+ T cells were purified from human blood and infected with live 
KHW (KHW) or fliC deletion KHW mutant (KHWFliCKO) at an MOI of approximately 
30:1 for 2 hours followed by 22 hour exposure to 2.5 µg/ml of surface-bound anti-CD3. 
IL-2 levels in the cell supernatants were determined by ELISA. There was no detectable 
IL-2 secretion by uninfected cells upon exposure to TCR stimulation. In the absence of 
anti-CD3 stimulation, there was also no detectable IL-2 secretion by T cells with or 
without bacterial infection (data not plotted). The experiment was repeated at least three 







Reduced IL-2 production by B3Z T cells infected with B. pseudomallei strain KHW 
Previously, we showed that B. pseudomallei could invade and replicate within 
mouse B3Z CD8+ T cell lines. We decided to test if the costimulatory effects of B. 
pseudomallei strain KHW observed in human Jurkat T cells was also seen in mouse T 
cells. When B3Z T cells were infected with live B. pseudomallei strain KHW at MOI 
30:1, followed by exposure to TCR stimuli supplied in the form of surface-coated anti-
CD3 mAbs, they produced significantly less amounts of IL-2 as compared to uninfected 
cells (Fig 3.10A). B3Z T-cell line is a T cell hybridoma that recognizes SIINFEKL OVA 
peptide in association with H-2Kb. Hence, to determine if IL-2 response to antigenic 
stimulation was similarly affected, T cells infected at MOI 30:1 were exposed to OVA 
peptide presented by DC2.4 cells (H-2b) and were similarly found to produce lower 
amounts of IL-2 as compared to uninfected cells (Fig 3.10B). Infection at MOI 5:1 
however, did not result in an appreciable reduction in IL-2 production by infected cells in 
response to both TCR and peptide stimuli, indicating that larger numbers of bacteria are 
necessary to affect T cell function.  
Cells were infected for 2 hours followed by 18 hour incubation with anti-CD3 
mAb or DC2.4 cells with bound peptides, resulting in a total time of 20 hours of 
infection, at which time cell supernatant was assayed for IL-2 levels. Cell viability of 
infected B3Z T cells started to decrease at this time point onwards. Hence, the decrease in 
IL-2 amounts produced by infected cells could be attributed to bacteria-induced cell 
death. DC2.4 cells were fixed with 1% formaldehyde before pulsing with OVA peptides 


































Figure 3.10 IL-2 production by B. pseudomallei strain KHW-infected B3Z T cells 
after exposure to TCR or antigenic stimuli 
 
B3Z T cells were infected with B. pseudomallei strain KHW at an MOI of approximately 
5:1 and 30:1 for 2 hours followed by an 18 hour exposure to surface bound anti-CD3 
mAbs (TCR stimulation) (A), or SL8 OVA peptide pulsed on DC2.4 cell (antigenic 
stimulation) (B). IL-2 levels in the cell supernatant were determined by ELISA. In the 
absence of TCR or peptide stimulus, there was no detectable IL-2 secretion by T cells in 
the presence or absence of bacterial infection. The experiment was repeated at least three 






















































B. pseudomallei was previously shown to be able to invade and replicate 
intracellularly within human and mouse T cell lines. However, rapid cell death was not 
observed in infected T cells as in dendritic cells. We postulated that during the earlier 
hours of infection when the infected cell is still viable, there is a time period of 
coexistence between the bacterium and the host cell, during which B. pseudomallei could 
alter host T cell function.  
 To test whether human Jurkat CD4+ T cells infected with virulent B. 
pseudomallei strain KHW show any altered response to TCR stimulation, we measured 
IL-2 production by the infected cells upon engaging their TCR with CD3-specific 
antibodies, which are known to stimulate IL-2 production in Jurkat cells. The αβ-TCR 
heterodimer is associated on the cytoplasmic side with CD3 polypeptide chains that 
mediate signal transduction across the plasma membrane via motifs involved in linking 
surface TCR to intracellular signaling effectors (Weiss et al., 1984, Weiss and Littman, 
1994, Abraham and Weiss, 2004). IL-2 is a crucial "T cell growth factor" that stimulates 
proliferation of antigen-primed T cells in an autocrine fashion (Kouttab et al., 1984).  
Yersinia tyrosine phosphatase, YopH, targets and inhibits signaling intermediates 
crucial for TCR-mediated signaling such as Lck, a TCR-associated protein tyrosine 
kinase (Alonso et al., 2004, Gerke et al., 2005). Interestingly, we found B. pseudomallei 
did not negatively modulate T cell activation signaling pathways, at least during the first 
22 hours of bacteria-host cell interaction. In fact, we observed an enhanced IL-2 
production by B. pseudomallei infected Jurkat T cells as compared to uninfected T cells 
upon TCR engagement. This suggests that unlike infectious pathogens such as Yersinia, 
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B. pseudomallei did not compromise host T cell-mediated immune responses by affecting 
T cell activation. 
  In contrast, costimulatory effect of B. pseudomallei was not observed for mouse 
CD8+ B3Z T cells. B. pseudomallei infected B3Z T cells produced less IL-2 than infected 
cells in response to both TCR and peptide stimuli. This can be correlated to earlier data 
that showed death of infected B3Z T cells at 22 hours after infection, the time which 
cellular supernatant was harvested and assayed for IL-2. Hence, future studies on 
bacterial costimulation of B3Z T cells should involve shorter assay time points. For 
instance, IL-2 mRNA expression can be measured instead of IL-2 secretion.  
Enhanced IL-2 production upon TCR engagement was also observed when Jurkat 
cells were incubated with B. pseudomallei strain KHW in a transwell set up to prevent 
bacteria-cell contact or with the bacterial culture supernatant. This indicates that B. 
pseudomallei’s costimulation of T cells was not solely dependent on bacterial contact or 
entry, and that the bacteria could be releasing a factor that can also costimulate T cells 
resulting in their increased IL-2 production. In all cases, infection with live bacteria 
resulted in a significantly greater enhancement of IL-2 production as compared to 
incubation with bacteria in a transwell set up or with bacterial culture supernatant. This 
suggests that B. pseudomallei’s costimulation of host T cells could be more potent in the 
event when bacteria are allowed to contact the cells while at the same time,  
costimulatory bacterial factors are also released by the bacteria onto the cells.  
T cell stimulation by antigen follows a “two signal hypothesis” where the first 
signal is provided by ligation of TCR by peptide-MHC complexes that primes the T cell 
for proliferation and differentiation, and the second signal consists of a set of co-stimuli 
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conferred by counter-receptors expressed by APCs or by soluble factors including 
cytokines and chemokines. Co-stimuli are crucial for promoting T cell-cycle progression 
leading to naïve T cell clonal expansion and differentiation into effector T cells (Lafferty 
et al., 1980, Jenkins et al., 1990, Johnson and Jenkins, 1993). The most prominent T cell 
costimulatory receptor is CD28, which binds to CD80/ CD86 ligands expressed at high 
levels by activated professional APCs such as macrophages and dendritic cells (Jenkins 
and Johnson, 1993). Ligation of CD28 amplifies TCR-mediated T cell activation through 
activation of signaling effectors shared by the TCR. The lack of CD28-mediated 
costimulation results in reduced T cell proliferation and reduced T helper cell 
differentiation and cytotoxic T cell responses (Lucas et al., 1995, Rulifson et al., 1997, 
Prilliman et al., 2002).  
CD28-deficient mice have reduced responses to infectious pathogens such as 
Listeria monocytogenes and Leishmania major (Mittrucker et al., 2001, Compton and 
Farrell, 2002). Hence, costimulation of T cells is a crucial hallmark for development of 
efficient T cell-mediated immune responses against pathogens. Our study provides 
evidence that, in addition to CD28 costimulatory signals provided by APCs, the bacterial 
pathogen can directly provide a similar costimulatory signal, either as a component 
attached to the live organism or a secreted factor, which enhances T cell activation by 
amplifying TCR-mediated signals leading to increased IL-2 production.  
Flagellin is a known ligand for innate immune receptor, TLR5, that is expressed 
on T cell surface (Hornung et al., 2002, Hayashi et al., 2001, Smith and Ozinsky, 2002). 
The use of an isogenic fliC deletion mutant have shown that costimulatory effects of live 
B. pseudomallei is only partially due to the presence of flagellin and that there are other 
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costimulatory components associated with the bacteria that can act in synergy with TCR-
mediated signals. In contrary, bacterial culture supernatant from the fliC deletion mutant 
was completely unable to enhance IL-2 production in T cells upon TCR stimulation. 
Hence, flagellin is likely to be the predominant costimulatory component secreted by B. 
pseudomallei.  This is also seen with E. coli, where bacterial supernatant from E. coli fliC 
deletion mutant was clearly shown to be completely unable to costimulate Jurkat T cells.  
Flagellin monomer makes up flagella filament and is known to be secreted by 
bacteria through an export machinery made up of the basal body, the hook, and the 
filament in the flagella structure (Shapiro, 1995, Macnab, 1999). Monomeric flagellin is 
normally found in supernatants of motile bacteria e.g. Salmonella, consistent with the 
detection of FliC in supernatants of B. pseudomallei in our study. Monomeric flagellin is 
also more stimulatory for TLR5 than polymeric flagellin (Smith et al., 2003). This 
explains that in the case of live B. pseudomallei, flagellin as part of the bacterial flagella 
is unlikely to be the main contributor to costimulatory effects seen. Instead, the live 
bacteria seem to possess other costimulatory components. The reduced costimulatory 
effect seen with the live fliC deletion B. pseudomallei mutant could be because no 
flagellin monomer is secreted onto the cells during live bacterial infection.  
Heat-killed B. pseudomallei are completely unable to costimulate T cells, while 
heat-treated bacterial supernatant was still able to costimulate Jurkat T cells. This 
indicates that the epitope of the secreted flagellin monomer involved in binding to TLR5 
is apparently not destroyed upon heat treatment. The absence of T cell costimulation by 
heat-killed B. pseudomallei could be because flagellin monomers were not being secreted 
onto T cells or other costimulatory components had been destroyed by heat. Hence, B. 
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pseudomallei’s costimulation of T cells could either be due to the presence of heat-labile 
bacterial components or is essentially dependent on the bacteria being alive and hence 
able to interact with host T cells. 
 Interestingly, results from bsaQ, B. thailandensis as well as E. coli studies 
demonstrate that costimulation of T cells by B. pseudomallei is independent of a 
functional type III secretion apparatus and is not unique to a particular bacteria species. 
Both WT B. pseudomallei and E. coli bacteria and supernatant were also able to 
costimulate T cells and flagellin was found to be the predominant costimulatory 
component in the bacterial supernatant of both species. Thus, it is possible that the 
costimulatory components associated with live B. pseudomallei could likely be general 
pathogen-associated molecules such as flagellin.  
Other unidentified costimulatory components in addition to flagellin were found 
to be associated with the live B. pseudomallei. However, this may not be the case for E. 
coli, since fliC deletion E. coli mutant bacteria was found to be unable to enhance Jurkat 
T cell IL-2 production compared to the WT E. coli. During the E. coli experiments, 
tetracycline or streptomycin was added after 2 hours of infection to suppress bacterial 
growth during the subsequent incubation period with anti-CD3 mAbs. However, the 
growth of the E.coliFliCKO bacteria was not found to be completely suppressed 
compared to the WT E. coli. The failure to observe any costimulatory effects with live E. 
coliFliCKO might be a result of the cells being unhealthy due to bacterial growth in the 
medium. Hence, it cannot be concluded if flagellin is the main costimulatory component 
associated with live E. coli. 
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On one hand, flagellin is a common PAMP molecule, while on the other, flagella 
function is an important virulence factor of pathogens such as B. pseudomallei and 
Salmonella (Carsiotis et al., 1984, Chua et al., 2003). This creates a paradox whereby the 
same virulence factor of the pathogen can also costimulate T cells. At the same time as 
bacterial costimulation helps the host to develop protective immunity more efficiently, 
excessive inflammation may occur if the costimulatory signal is too strong and poorly 
regulated leading to overexpansion of effector T cells. It is important for the strength of 
costimulatory signals to be controlled. In our study, B. pseudomallei’s interaction with 
host T cells alone cannot stimulate them. Enhancement in IL-2 production was observed 
only when T cells treated with bacteria are supplied with TCR stimulus. This specificity 
possibly controls for excessive inflammation due to overexpansion of effector T cells.  
Our findings that B. pseudomallei can costimulate T cells together with TCR 
activation can be correlated to clinical studies on in vitro lymphocyte responses to B. 
pseudomallei antigens.  Lymphocytes taken from subjects who have recovered from 
melioidosis or from seropositive yet healthy asymptomatic individuals, showed enhanced 
proliferation and IFNγ production in response to B. pseudomallei antigens, in comparison 
to serologically negative control subjects without clinical history of infection (Ketheesan 
et al., 2002, Barnes et al., 2004). The presence of memory antigen-specific T cells in 
these subjects provides evidence that CMI was developed during infection to control 
disease progression. In their studies, lymphocytes taken from subjects were stimulated 
with a cocktail of antigens prepared by sonication of B. pseudomallei. Such a lysate 
preparation could contain immunogenic antigens as well as costimulatory bacterial 
components. Note that PBMCs taken from subjects were stimulated as a whole 
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population. In the context of the T lymphocytes, the enhanced lymphocyte proliferation 
and IFNγ production could be a result of costimulation by bacterial costimulatory ligands 
in synergy with antigenic stimulation of TCR on lymphocytes. In these clinical studies, 
memory antigen-specific lymphocytes were tested for response to antigens prepared from 
B. pseudomallei lysate, while in our study, responses of Jurkat T cell line to live B. 
pseudomallei and their secreted factors are studied.  
B. pseudomallei costimulation was also seen for primary CD4+ T cells isolated 
from human PBMCs, supporting the physiological relevance of the in vitro observations 
with Jurkat T cells. It is evident from our work that the pathogen can directly costimulate 
primary human T cells. Future work should focus on determining if this bacterial 
costimulation can affect parameters of T cell activation, other than IL-2 production. 
Furthermore, effects of bacterial costimulation on different subsets of T cells including 
regulatory and memory T cells should be explored. Importantly, B. pseudomallei clearly 
possesses costimulatory components other than flagellin, which remains to be discovered. 
Discovery of potent T cell costimulatory components associated with the pathogen and 
how the host T cells respond to them will expand the list of vaccine candidates for 
protection against B. pseudomallei infection. This is especially so since effector T cells 
are known to be important for host defenses against this pathogen. At the same time, 
potent T cell costimulation by B. pseudomallei can help to explain the pathophysiology 
associated with septicemic melioidosis possibly as a result of overexpansion of T cells 


















IN VITRO STUDIES ON INTERACTION OF BURKHOLDERIA 



















Engagement of the TCR with antigenic peptides in association with MHC 
molecules leads to a series of intracellular signaling events resulting in transcription of 
genes involved in T cell proliferation and differentiation. However, TCR ligation alone is 
insufficient for T cell activation and a second costimulatory signal is required (Jenkins et 
al., 1990, Johnson and Jenkins, 1993). The latter can be triggered by ligation of 
costimulatory receptors on T cells. For example, CD28 and CD40L are two prominent T 
cell costimulatory receptors that recognize CD80/ CD86 and CD40 expressed at high 
levels on activated professional APCs respectively (Jenkins and Johnson, 1993, Mondino 
and Jenkins, 1994). In particular, CD28-mediated costimulation in T cells has been well 
studied. Many T cell responses are significantly compromised in CD28-deficient mice, 
which have reduced cell-mediated immune responses to infectious pathogens (Shahinian 
et al., 1993, Compton and Farrell, 2002).  
  Pattern recognition receptors such as TLRs that recognize bacterial PAMPs have 
generally been associated with innate cells such as macrophages and neutrophils which 
become activated to kill infectious pathogens upon ligation of their TLRs. Binding of 
PAMPs to TLRs on DCs are needed for their maturation into cells capable of activating T 
cells to initiate CMI responses (Aderem and Ulevitch, 2000, Iwasaki and Medzhitov, 
2004). Interestingly, it was shown that T cells also express TLRs mRNA (Hornung et al., 
2002, Zarember and Godowski, 2002). In addition to indirect effects on CMI via their 
action on DCs, TLRs have been shown to function as costimulatory receptors that can 
directly influence T cell function in the absence of APCs. For example, ligation of TLR2, 
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TLR7/8  and TLR5 synergize with TCR signals to enhance proliferation and cytokine 
production by human CD4+  T cells (Caron et al., 2005, Xu et al., 2005, Liu et al., 2006).  
Flagellin monomer is the known ligand for TLR5 and polymerizes to form 
bacterial flagella, a virulence factor for many pathogens such as B. pseudomallei  
(Hayashi et al., 2001, Chua et al., 2003). Flagellin has been shown to induce cytokine 
production by NK cells and monocytes (Hayashi et al., 2001, Chalifour et al., 2004). 
Now, there is growing evidence showing that flagellin, together with TCR signals, can 
costimulate CD4+ T cells resulting in enhanced T cell responses as well as having direct 
effects on modulating regulatory T cell function (Crellin et al., 2005, Caron et al., 2005). 
Such a direct contact between TLRs and pathogenic costimulatory signals has been 
shown in B. pseudomallei interaction with T cells. I have shown in the previous chapter 
that live B. pseudomallei, as well as other bacterial species like E. coli and B. 
thailandensis, could potently costimulate T cells, leading to augmented IL-2 production. 
Flagellin was found to be one of the costimulatory components associated with live B. 
pseudomallei and flagellin secreted by the bacteria contributed mainly to the 
costimulatory effects of bacterial supernatant.  
 Here, we investigated the direct effects of recombinant purified B. pseudomallei 
flagellin on human Jurkat CD4+ T cells, as well as primary human CD4+ and CD8+ T 
cells purified from PBMCs. To date, costimulatory effects of flagellin have not been 
tested on primary human CD8+ T cells. Furthermore, enhanced cytokine production has 
so far been shown only at the protein level and not at the transcript level. CD28 
costimulation is known to potently enhance IL-2 production (Jenkins et al., 1991) and the 
regulation of which can be attributed to enhancement of mRNA stability together with 
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increased transcript expression (Sanchez-Lockhart et al., 2004, Sanchez-Lockhart and 
Miller, 2006). Hence, through reverse transcription and real time PCR techniques, IL-2 
transcript expression levels as well as mRNA stability upon flagellin costimulation of T 
cells were determined. Such information is useful for future signaling studies to elucidate 
how TLR5 signaling pathway synergizes with TCR-mediated signals at the molecular 
level to enhance T cell responses.  
 We also investigated the costimulatory effects of both LPS (TLR4 ligand) and 
PAM3CysSK4 (TLR2 ligand) on Jurkat T cells and primary human T cells. These results 
are interpreted together with that of flagellin costimulation, to ensure that any observed 
costimulatory effect of flagellin on augmenting IL-2 production in T cells was not due to 



























MATERIALS AND METHODS 
 
Culture and maintenance of cell lines 
 
Jurkat T cells and HEK293T were cultured and maintained as described in 
Chapter 2 Materials and Methods section, except DMEM medium (Sigma, St. Louis, 
MO) was used for HEK293T, a kind gift from Dr. Lu Jinhua (Dept. of Microbiology, 
NUS). 
Isolation of human CD4+ and CD8+ T cells from blood 
 
Around 50 ml of human blood was separated using Histopaque-1077 (Sigma, St. 
Louis, MO) according to the manufacturer’s protocol. Buffy coat containing the 
peripheral blood mononuclear cells (PBMCs) were isolated and washed 2 times with 
PBS. Cells were resuspended in de-gassed buffer (PBS, 2 mM EDTA and 1 % FBS; pH 
7.2) and magnetically labeled with 20 µl of CD4 or CD8 Microbeads (Miltenyi, Bergisch 
Gladbach, Germany) per 1 x 107 cells for 15 minutes on ice. After washing once with de-
gassed buffer, cell suspension (up to 100 x 106 cells) was loaded onto a Magnetic cell 
sorting (MACS) column that is placed in the magnetic field of a MACS separator 
(Miltenyi). Magnetically labeled CD4+ or CD8+ cells were retained on the column while 
unlabelled cells were allowed to flow through the column. The bound column was 
washed 3 times with 0.5 ml de-gassed buffer each time. The column was removed from 
the magnet and retained labeled cells were eluted by applying the plunger filled with 2 ml 
of de-gassed buffer. CD4+ or CD8+ T cells were used for costimulation experiments. The 
purity of the separated CD4+ and CD8+ T cell fractions were analyzed by flow cytometry.   
Bacterial proteins and antibodies 
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Ultra pure lipopolysaccharide (LPS) and Pam3Cys-Ser-Lys4 (PAM3CysSK4), 
which are TLR4 and TL2 ligands respectively were purchased from Invivogen, San 
Diego, CA. Anti-CD3 mAb that reacts with the human CD3 ε-chain, a 20-kDa subunit of 
CD3/ TCR complex was purchased from BD Pharmingen. Anti-CD28 mAb was 
purchased from BioLegend, San Diego, CA. Recombinant B. pseudomallei FliC protein 
was prepared by Ng H. L. in our laboratory.  
Costimulation of cells 
 
Jurkat T cells or primary human T cells were seeded at a cell density of 0.2 x 106 
cells/ml into 96-well plates previously coated with 2.5 µg/ml of anti-CD3 mAb. Cells 
were costimulated with various concentrations of flagellin, anti-CD28 mAbs, LPS or 




Jurkat T cells were seeded at a cell density of 2.0 x 106 cells/ml in medium into 
12-well plates previously coated with 2.5 µg/ml of anti-CD3 mAb. Recombinant B. 
pseudomallei flagellin was added at a concentration of 1 ng/ml as a costimulus. Cells 
were stimulated with anti-CD3 with or without flagellin for 5 hours at 37°C with 5 % 
CO2. Total RNA was isolated from the cells using Trizol® (Invitrogen Life Technologies) 
according to the manufacturer’s protocol. Briefly, 2.0 x 106 cells were pelleted and lysed 
in 1 ml of Trizol® reagent, followed by addition of 200 µl of chloroform. After 
centrifugation, the colorless upper aqueous phase containing RNA was transferred to a 
fresh tube. 0.5 ml of isopropanol was added to precipitate the RNA and the pellet was 
washed in 75 % ethanol, air-dried and redissolved in 10 µl of DEPC-treated RNAse-free 
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water. 5 µg of RNA was subjected to reverse transcription to cDNA using M-MLV 
reverse transcriptase enzyme and oligo-dT primers (Promega, Madison, WI) according to 
the manufacturer’s protocol. PCR was performed using Taq polymerase (Promega) in 50 
mM MgCl2 buffer in a PTC-100 thermocycler (MJ Research Inc., Boston, MA). The 
cycling parameters for amplification with IL-2-specific primers IL-2F 
(5’AACTCACCAGGATGCTCACA3’); IL-2R (5’GCACTTCCTCCAGAGGTTTG3’), 
or TLR5-specific primers TLR5F (5’CATTGTATGCACTGTCACTC3’); TLR5R 
(5’CCACCACCATGATGAGAGCA3’), or GAPDH-specific primers GAPDHF 
(5’GAAGGTGAAGGTCGGAGTC3’);  
GAPDHR (5’GAAGATGGTGATGGGATTTC3’) were as follows: 1 cycle of 
denaturation at 94°C for 5 min and 30 cycles at 94°C for 30s, 55°C (59°C for IL-2) for 
30s, and 72°C for 1 min, followed by 1 cycle at 72°C for 10 min.  
Real time PCR  
 
Jurkat T cells were seeded at a cell density of 2.0 x 106 /ml in medium into 12-
well plates previously coated with 2.5 µg/ml of anti-CD3 mAb. 1 ng/ml of recombinant 
B. pseudomallei flagellin or 1 µg /ml of soluble anti-CD28 mAb were added. Cells were 
stimulated with anti-CD3 with or without flagellin or anti-CD28 mAbs for 5 hours, after 
which 0.5 µg/ml of cyclosporin A (CsA) (Calbiochem, San Diego, CA) was added to 
inhibit transcription. At 0, 1 and 2 hours after addtition of CsA, total RNA was isolated 
from the cells using Trizol® (Invitrogen Life Technologies) according to he 
manufacturer’s protocol. For each sample, 1 µg of RNA was subjected to reverse 
transcription to cDNA using TaqMan® reverse transcriptase reagents kit (Applied 
Biosystems, UK) according to the manufacturer’s protocol. Real-Time PCR was 
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performed with Applied Biosystems 7500 Real-Time PCR system using 100 ng cDNA 
template for each sample that was mixed with target IL-2 or endogenous gene GAPDH -
specific primers and Power SYBR® green master mix containing AmpliTaq Gold® 
polymerase (Applied Biosystems). The cycling parameters for amplification with the 
gene specific primers were as follows: 1 cycle of polymerase activation at 95°C for 10 
min and 40 cycles at 95°C for 15s and 60°C for 1 min. PCR cycling for each cDNA 
sample was performed in triplicates. IL-2-specific primers used were IL-2F 
(5’CTGGAGCATTTACTGCTGGATTT3’)                     
and IL-2R (5’TGGTGAGTTTGGGATTCTTGTAATT3’). GAPDH-specific primers 
used were GAPDHF (5’ATGGAAATCCCATCACCATCTT3’) and GAPDHR 
(5’CGCCCCACTTGATTTTGG3’).  
Transfection and Detection of NF-κB activation 
 
HEK293T cells were seeded at a cell density of 0.2 x 106 cells/ml in medium into 
24-well plates 24 hours before transfection. The cells were transfected with 0.2 µg of two 
luciferase reporter plasmids; p5xNF-κB-luc (Stratagene, La Jolla, CA) and pRL-CMV 
(Promega, Madison, WI). Cells were also co-transfected with 0.1 µg TLR2 plasmid or 
pcDNA control plasmid, kind gifts from Dr. Lu Jinhua (Dept. of Microbiology, NUS). 
GenePORTER 2 reagent was used for the transfections (Gene Therapy System, La Jolla, 
CA). 24 hours after transfection, cells were stimulated with 1 ng/ml of flagellin or 1 
µg/ml of PAM
 
for 7 hours. After this, cells were lysed with passive lysis buffer (PBL) 
(Promega) in the wells. The plate was placed on a shaking incubator for 40 min to 
facilitate cell lysis. The lysate was diluted 50 x and 2 µl of the lysate was used for 
determining luciferase expression using the Dual Luciferase Assay Kit to detect NF-κB 
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activation (Promega). Luminescence emitted was expressed as a ratio: Firefly luciferase 
activity / Renilla luciferase activity. Background luminescence ratio of untreated pcDNA-
transfected cells were subtracted from that of pcDNA or TLR2-transfected cells treated 
with flagellin or PAM. 
Cytokine measurement 
 
At time points indicated, cell supernatant was harvested and production of IL-2 cytokine 
by infected Jurkat and B3Z T cells upon TCR engagement was measured by ELISA 
according to manufacturer’s protocol (BD Pharmingen).  
Flow cytometric analysis 
 
0.2 x 105 cells were incubated at 4°C for 1 hour with PE-conjugated anti-CD4 or CD8 
monoclonal antibodies (BD Pharmingen). Fluorescence was measured using a Becton 
















Costimulatory effects of B. pseudomallei flagellin and anti-CD28 mAb on IL-2 
secretion by Jurkat T cells 
 
When Jurkat T cells were incubated with surface-coated anti-CD3 mAb and 
flagellin for 24 hours, very high amounts of IL-2 cytokine were detected in the 
supernatant. In the presence of 0.5 ng/ml of flagellin and 2.5 µg/ml of anti-CD3 mAb, 
Jurkat cells secreted 8.5 fold higher amounts of IL-2 as compared to cells stimulated with 
anti-CD3 mAb alone. Even in the presence of low concentrations of 62.5 pg/ml flagellin, 
a 2.4 fold increase in IL-2 levels was detected compared to stimulation with anti-CD3 
alone (Fig 4.1). Low levels of IL-2 can be detected when cells were stimulated with anti-
CD3 alone, indicating that triggering the TCR-mediated signaling pathway is sufficient to 
result in basal levels of IL-2 production by T cells. However, IL-2 was not detected in 
supernatants of cells stimulated with flagellin alone in the absence of anti-CD3 
stimulation (Fig 4.1). This shows that triggering the TLR5 signaling pathway in T cells 
via binding of flagellin is insufficient to result in IL-2 production. Instead, flagellin needs 
to be supplied as a costimulus together with a TCR ligand to exert effects on T cell 
function.  
When Jurkat T cells were costimulated with 2 µg/ml or 50 ng/ml of anti-CD28 
mAbs, they produced 6.9 fold and 3.4 fold higher IL-2 amounts than cells stimulated with 
anti-CD3 mAb alone, respectively (Fig 4.2). Flagellin costimulation seems to be more 
potent than CD28 costimulation where 0.5 ng/ml of flagellin can result in 8.5 fold 
increase in IL-2 production. In fact, when 1 µg/ml of anti-CD28 mAbs was added 
together with 100 pg/ml of flagellin, an enhancement of 10 times in IL-2 levels was 
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detected in the cellular supernatant (Fig 4.1 and 4.2). Therefore, both flagellin and CD28 
costimulation have an additive effect in augmenting TCR-mediated signals.  
Costimulatory effects of bacterial flagellin on expression of IL-2 mRNA transcript 
by Jurkat T cells 
 
Semi-quantitative reverse transcription PCR was performed to determine if the 
increased amounts of IL-2 secreted by Jurkat cells upon flagellin costimulation with TCR 
stimulus is a result of increased levels of IL-2 mRNA transcripts. In the absence of any 
stimulus, IL-2 mRNA transcript was completely not detected. When anti-CD3 stimulus 
was supplied, low levels of IL-2 transcripts could be detected. Cells that were 
costimulated with anti-CD3 mAb alone exhibited a 1.3 fold increase in IL-2 transcript 
levels compared to non-stimulated cells (Fig 4.3A and B). Costimulation of T cells with 
both 1 ng/ml of flagellin and anti-CD3 mAb resulted in a 3.7 fold increase in IL-2 mRNA 
transcript levels compared to non-stimulated cells and a 2.9 fold increase in IL-2 
transcript levels compared to cells stimulated with anti-CD3 mAb alone (Fig 4.3A and 
B). This indicates that flagellin costimulation results in increased transcription of IL-2 
gene, which could account for the increase in IL-2 secretion by costimulated Jurkat T 
cells. 
Using reverse-transcription PCR, Jurkat T cells were also found to express TLR5 
mRNA transcript (Fig 4.4A). Unlike the observations for IL-2 mRNA transcript, basal 
levels of TLR5 transcript could be detected in non-stimulated cells (Fig 4.4A). 
Interestingly, stimulation of T cells with anti-CD3 mAb alone resulted in 1.7 fold 
increase in TLR5 transcript levels compared to non-stimulated cells (Fig 4.4A and B). 
Stimulation of T cells with anti-CD3 mAb and 1 ng/ml flagellin resulted in 1.1 fold 
higher amounts of TLR5 transcripts compared to non-stimulated cells (Fig 4.4A and B). 
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This shows that TLR5 gene expression could be up-regulated when TCR-mediated 
signaling pathways are triggered in Jurkat T cells.  
Real time PCR was then carried out to provide a more accurate quantification of 
IL-2 transcripts and to determine if the increased IL-2 transcript levels were due to higher 
expression or enhanced stability of the mRNA. Relative quantitation gene expression was 
used to quantify differences in the expression level of the IL-2 target gene in Jurkat cells 
with different treatments. Cells stimulated anti-CD3 mAb alone, anti-CD3 and 1 ng/ml of 
flagellin, or anti-CD3 and anti-CD28 for 5 hours, exhibited a 3.2, 129.7 and 27.7 fold 
higher expression level of IL-2 gene than the untreated cells, respectively (Fig 4.5A). 
This indicates that flagellin costimulation significantly increases IL-2 mRNA transcript 
production to a greater extent compared to CD28 costimulation. During the first hour of 
CsA addition, IL-2 mRNA from flagellin-costimulated cells underwent rapid degradation 
(down to 14 %) at a faster rate compared to mRNA from CD28-costimulated cells (down 
to 51 %) (Fig 4.5B). However, even at 1 and 2 hours after addition of CsA,  flagellin-
costimulated cells were found to express a IL-2 mRNA fold change of 23.5 and 47 
respectively, which is greater than that seen for CD28-costimulated cells (Fig 4.5A). 
CD28 costimulation appears to slightly stabilize IL-2 mRNA after 1 hour of CsA addition 
indicated by a lower rate of mRNA degradation compared to within the first hour of CsA 
addition (Fig. 4.5B). For flagellin stimulation, mRNA degradation was halted after 1 hour 
of CsA addition, showing a stabilization of IL-2 mRNA. Hence, flagellin costimulation 
primarily enhances IL-2 secretion in Jurkat cells through significantly augmenting 
mRNA transcript generation but at later time points also mRNA stability. 
IL-2 response of Jurkat T cells to LPS and PAM3CysSK4 as costimulatory molecules 
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To rule out costimulation by any LPS or bacterial lipoprotein contaminants in 
purified flagellin preparations we used, we separately tested the costimulatory effects of 
LPS and PAM, which are agonists for TLR4 and TLR2 respectively. When 1 µg/ml of 
PAM or 2 µg/ml LPS were supplied together with 2.5 µg/ml of anti-CD3 mAb, amounts 
of secreted IL-2 detected was similar to that of cells stimulated with anti-CD3 mAb alone 
(Fig 4.6). High levels of IL-2 were detected in the positive control in which the cells were 
stimulated with 10 ng/ml of phorbol 12-myristate 13-acetate (PMA) and 0.5 µg/ml of 
ionomycin (a calcium ionophore), indicating that the cells tested were capable of 
producing IL-2 higher than that of basal levels (Fig 4.6). The failure of PAM or LPS to 
enhance IL-2 production in response to anti-CD3 stimulation could mean that Jurkat T 
cells do not express TLR2 or TLR4. Indeed, we found that Jurkat cells do not express 
TLR 2 and 4 transcripts (data not shown). Altogether, the results indicate that in Jurkat 
cells, the costimulatory effect of flagellin with TCR stimulation on IL-2 production could 
not be due to LPS or lipoprotein contamination of flagellin purified from bacterial source.  
Costimulatory effects of bacterial flagellin on IL-2 production by primary human 
CD4+ and CD8+ T cells 
 
We isolated CD4+ and CD8+ T cell subsets from PBMCs and tested if they 
responded similarly to costimulation by bacterial flagellin as seen for the Jurkat E6-1 
clone, a CD4+ T cell line. CD4+ and CD8+ T cells were isolated from PBMCs with anti-
CD4 or -CD8 antibody-coated magnetic beads through MACS. For each experimental 
attempt, flow cytometric analysis revealed more than 98% purity for each CD4+ or CD8+ 
cell fraction (Fig 4.7).  
When CD4+ T cells and CD8+ T cells were stimulated with 2.5 µg/ml of anti-CD3 
mAbs together with 2 or 1 ng/ml of flagellin, they secreted an average of 1.85 fold and 
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3.7 fold higher amounts of IL-2, respectively, as compared to cells stimulated with anti-
CD3 mAb alone (Fig 4.8A and B). Primary human T cells do not produce as much IL-2 
in response to flagellin costimulation as compared to Jurkat E6-1 clone, a T cell leukemia 
line known to secrete very high amounts of IL-2 after stimulation. A longer period of 
costimulation of 30 hours was also required to detect IL-2 levels in supernatants of the 
human T cells. For both subsets of T cells, although the basal amount of IL-2 levels 
secreted in response to anti-CD3 stimulation alone varied across experiments, the fold 
increase in IL-2 levels after flagellin costimulation was consistent (Fig 4.8). The results 
from the human T cell costimulation study indicates that flagellin costimulation is able to 
enhance TCR-mediated signaling pathway leading to augmented cytokine production in 
human CD4 and CD8 expressing T cells.  
IL-2 response of primary human T cells to LPS and PAM3CysSK4 as costimulatory 
molecules 
  
In contrast to Jurkat T cells, primary human CD4+ and CD8+ T cells were 
previously found to express TLR2, TLR4 and TLR5 mRNA transcripts. Hence, we tested 
the costimulatory effect of LPS and PAM on IL-2 production in these cells. For both T 
cell subsets, when 1 µg/ml LPS was added together with 2.5 µg/ml of anti-CD3 mAb, IL-
2 levels detected in the cellular supernatant were similar to that of cells stimulated with 
anti-CD3 mAb alone (Fig 4.9A and B). Hence, the costimulatory effect of flagellin with 
TCR stimulation on IL-2 production could not be due to LPS contamination of flagellin 
purified from bacterial source. In contrary to Jurkat T cells studies, CD4 and CD8 
expressing T cells secreted 8.7 and 14.5 fold higher amounts of IL-2 in response to 1 
µg/ml of PAM
 
costimulation with anti-CD3 mAbs as compared to TCR stimulation alone 
(Fig 4.9A and B). This indicates that a more potent T cell costimulatory signal is 
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mediated through TLR2, since TLR2 costimulation could enhance IL-2 production in 
primary human T cells to a greater extent compared to flagellin costimulation.  
To rule out bacterial lipoprotein (TLR2 ligand) contamination in the flagellin 
preparation used for costimulation, we tested if the same batch of flagellin could activate 
NF-κB in HEK293T cells transfected with a TLR2 plasmid. We found that unlike PAM, 
1 ng/ml of flagellin was found not to activate NF-κB above basal levels in HEK293T 
cells transfected with TLR2 plasmid (Fig. 4.10). HEK293T cells are known to contain 
low levels of TLR5 expression, hence basal levels of NF-κB activation could be detected 
in pcDNA-transfected HEK293T cells stimulated with flagellin (Fig. 4.10). Hence, the 
flagellin preparation used for costimulation is unlikely to be contaminated with any 
bacterial lipoprotein and the costimulation effects on IL-2 production seen with primary 








































































































































































Figure 4.1 Costimulatory effects of B. pseudomallei flagellin protein on IL-2 
secretion by Jurkat T cells 
 
0.2 x 106 Jurkat T cells were stimulated with 2.5 µg/ml of anti-CD3 mAb coated onto a 
96-well plate in the presence of various concentrations of flagellin protein (Flag) as a 
costimulus. 24 hours after costimulation, IL-2 levels in the cell supernatant were 
determined by ELISA. In the presence of anti-CD3 mAb alone, low levels of IL-2 were 
detected. In the absence of any stimulus (cells alone) or in the presence of 1 ng/ml 
flagellin alone (flag alone), there was no detectable IL-2 secretion by T cells. The 
experiment was repeated at least three times and error bars represent the standard 








































































Figure 4.2 Costimulatory effects of CD28 agonist on IL-2 production by Jurkat T 
cells 
 
0.2 x 106 Jurkat T cells were stimulated with 2.5 µg/ml of anti-CD3 mAb coated onto a 
96-well plate in the presence of various concentrations of soluble anti-CD28 mAb as a 
costimulus. 24 hours after costimulation, IL-2 levels in the cell supernatant were 
determined by ELISA. In the presence of anti-CD3 mAb alone, low levels of IL-2 were 
detected. In the absence of any stimulus (cells alone) or in the presence of anti-CD28 
mAb alone (CD28 alone), there was no detectable IL-2 secretion by T cells. The 
experiment was repeated at least three times and error bars represent the standard 




















































































































Figure 4.3 Costimulatory effects of B. pseudomallei flagellin protein on IL-2 mRNA 
transcript expression in Jurkat T cells – reverse transcription PCR 
 
2.0 x 106 Jurkat T cells were incubated for 5 hours in the absence of stimulus (untreated), 
stimulated with 2.5 µg/ml of anti-CD3 mAb alone (CD3) or in the presence of 1 ng/ml of 
flagellin protein as a costimulus (CD3+ Flag). Total RNA was isolated from the cells 
followed by reverse-transcription PCR to determine IL-2 (A) expression. GAPDH served 
as the housekeeping gene and serial dilutions of its PCR products to determine a non-
saturating concentration was subjected to gel electrophoresis. GAPDH transcript 
expression was unvaried across samples. A 1 Kb DNA ladder was used as a marker to 
identify IL-2 and GAPDH PCR product of 105 bp and 226 bp respectively. Intensity of 
the PCR products bands was quantified by densitometry for target gene IL-2 (B). Treated 
samples (CD3 or CD3+Flag) were compared to untreated samples and calculated by the 
following formula: signal of target gene = target gene signal of sample relative to 
untreated sample/ GAPDH (100x) signal of sample relative to untreated sample; where 































































































































































































Figure 4.4 Costimulatory effects of B. pseudomallei flagellin protein on TLR5 
mRNA transcript expression in Jurkat T cells – reverse transcription PCR 
 
2.0 x 106 Jurkat T cells were incubated for 5 hours in the absence of stimulus (untreated), 
stimulated with 2.5 µg/ml of anti-CD3 mAb alone (CD3) or in the presence of 1 ng/ml of 
flagellin protein as a costimulus (CD3+ Flag). Total RNA was isolated from the cells 
followed by reverse-transcription PCR to determine TLR5 (A) expression. GAPDH 
served as the housekeeping gene and serial dilutions of its PCR products to determine a 
non-saturating concentration was subjected to gel electrophoresis. GAPDH transcript 
expression was unvaried across samples. A 1 Kb DNA ladder was used as a marker to 
identify TLR5 and GAPDH PCR product of 446 bp and 226 bp respectively. Intensity of 
the PCR products bands was quantified by densitometry for target gene TLR5 (B). 
Treated samples (CD3 or CD3+Flag) were compared to untreated samples and calculated 
by the following formula: signal of target gene = target gene signal of sample relative to 
untreated sample/ GAPDH (100x) signal of sample relative to untreated sample; where 













































































































Figure 4.5 Costimulatory effects of B. pseudomallei flagellin protein on IL-2 mRNA 
transcript expression and stability in Jurkat T cells – real time PCR relative 
quantitative expression 
 
2.0 x 106 Jurkat T cells were incubated for 5 hours in the absence of stimulus (untreated), 
in the presence of 2.5 µg/ml of anti-CD3 mAb alone (CD3), in the presence of anti-CD3 
with 1ng/ml of flagellin protein (CD3+Flag) or with 1 µg/ml of anti-CD28 mAb (CD3+ 
CD28) as a costimulus. 5 hours after stimulation, 0.5 ug/ml cyclosporin A (CsA) was 
added to inhibit further transcription. Total RNA was isolated from the cells at 5 hours 
after costimulation and without CsA addition (0h CsA), after 1 hour (1h CsA) and 2 
hours (2h CsA) of CsA addition. RNA was reverse transcribed to cDNA and the levels of 
both the target gene (IL-2) and endogenous control gene GAPDH were assessed by real 
time PCR. IL-2 expression levels in treated samples (CD3/ CD3+Flag/ CD3+CD28) are 
expressed as a fold change of expression levels relative to that in the calibrator sample 
(untreated cells at 0h CsA/ 1 h CsA/ 2h CsA) (A). Within each treatment (CD3/ 
CD3+Flag/ CD3+ CD28), % IL-2 mRNA in samples at 1h CsA and 2h CsA are 
expressed relative to the calibrator sample (CD3/ CD3+Flag/ CD3+CD28 at 0h CsA) (B). 
In both the treated and calibrator samples, the endogenous control gene was used to 
normalize the input amounts of the target gene cDNA templates used for real time PCR 
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Figure 4.6 Costimulatory effects of LPS and PAM3CysSK4 on IL-2 secretion by 
Jurkat T cells 
 
0.2 x 106 Jurkat T cells were stimulated with 2.5 µg/ml of anti-CD3 mAb coated onto a 
96-well plate in the presence of different concentrations of LPS (A) or PAM (B) as 
costimuli. 24 hours after costimulation, IL-2 levels in the cell supernatant were 
determined by ELISA. In the absence of any stimulus or in the presence of LPS or PAM 
alone, there was no detectable IL-2 secretion by the cells. Error bars represent the 































Figure 4.7 Flow cytometric analysis of CD4+ and CD8+ cell fractions purified from 
PBMCs 
 
0.2 x 106 of the cells PBMCs before separation were incubated with PE-conjugated anti-
CD4 (A) or anti-CD8 mAbs (B). 0.2 x 106 cells of the separated CD4+ or CD8+ cell 
fractions were stained with PE-conjugated anti-CD4 (C) or anti-CD8 mAbs (D). 
Following 1 hour of staining on ice, fluorescence was measured using the flow 
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Figure 4.8 Costimulatory effects of B. pseudomallei flagellin protein on IL-2 
secretion by primary human CD4+ and CD8+ T cells 
 
0.25 x 106 CD4+ (A) or CD8+ (B) T cells were stimulated with 2.5 µg/ml of anti-CD3 
mAb coated onto a 96-well plate in the presence of 1 ng/ml of flagellin protein as a 
costimulus. 30 hours after costimulation, IL-2 levels in the cell supernatant were 
determined by ELISA. In the absence of any stimulus or in the presence of flagellin 
alone, there was no detectable IL-2 secretion by T cells (not shown). The experiment was 









































































Figure 4.9 Costimulatory effects of LPS and PAM3CysSK4 on IL-2 secretion by 
primary human CD4+ and CD8+ T cells  
 
0.2 x 106 CD4+  (A) or CD8+  (B) T cells were stimulated with 2.5 µg/ml of anti-CD3 
mAb coated onto a 96-well plate in the presence of 1 µg/ml  of concentrations of LPS or  
PAM as costimuli. 30 hours after costimulation, IL-2 levels in the cell supernatant were 
determined by ELISA. In the absence of any stimulus or in the presence of LPS or PAM 
alone, there was no detectable IL- 2 secretion by the cells. Error bars represent the 





















































Figure 4.10 Effects of flagellin and PAM3CysSK4 on NF-κB activation in HEK293T 
cells transfected with TLR2 plasmid 
 
HEK293T cells were co-transfected with two luciferase reporter plasmids and TLR2 or 
pcDNA control plasmid, after which cells were stimulated with 1 ng/ml of flagellin 
(TLR2 + Flag/ pcDNA + Flag) or 1 µg/ml of PAM
 
(TLR2 + PAM/ pcDNA + PAM). 7 
hours after stimulation, NF-κB activation was detected by measuring luciferase 
expression using Dual Luciferase Assay Kit as described in Materials and Methods 
section. Luminescence emitted was expressed as a ratio: Firefly luciferase activity / 
Renilla luciferase activity. Background luminescence ratio of untreated pcDNA-
transfected cells were subtracted from that of pcDNA or TLR2-transfected cells treated 




Our previous data show that potent costimulatory effects of live B. pseudomallei 
on enhancing IL-2 secretion by Jurkat T cells upon their TCR engagement can be 
attributed to bacterial flagellin. To further confirm this finding, we tested the direct 
costimulatory effects of recombinant B. pseudomallei flagellin protein on Jurkat T cells 
as well as primary CD4+ and CD8+ T cells. We found that B. pseudomallei flagellin is 
indeed a strong T cell costimulatory molecule, where minimal concentrations of 
recombinant flagellin supplied together with anti-CD3 stimulation (TCR stimulus) are 
sufficient to result in increased IL-2 production by Jurkat T cells, equivalent and even 
superior to that achieved by CD28 costimulation. It is evident that both TLR5 and CD28 
costimulation can synergize with TCR-mediated signals to upregulate IL-2 production in 
T cells. Furthermore, when anti-CD28 and flagellin are supplied at the same time with 
TCR stimulus, there was an additive effect on the enhancement of IL-2 secretion by 
Jurkat T cells. This suggests that TLR5 and CD28 signaling could activate similar 
signaling effectors shared by the TCR, leading to enhancement of transcription factors 
that control IL-2 gene transcription. Flagellin costimulation also resulted in increased IL-
2 secretion by primary human CD4+ and CD8+ T cells purified from PBMCs. This 
supports the previous observations with transformed Jurkat T cell line.   
Our results pointing to TLR5-flagellin signaling as a potent costimulatory signal 
for T cell activation are consistent with recent studies reporting the direct effects of TLR 
ligands on T cells. It was shown that bacterial lipoprotein BLP, a TLR2 agonist, induced 
proliferation of CD4+ effector as well as regulatory T cells (Sutmuller et al., 2006, Liu et 
al., 2006). Flagellin, the TLR5 ligand, similarly enhanced proliferation and cytokine 
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production by human CD4+ T cells in synergy with TCR activation (Caron et al., 2005, 
Crellin et al., 2005). In particular, flagellin up-regulated T cell proliferation and IFN-γ 
production more efficiently in memory CD4+ T cells than naïve T cells (Caron et al., 
2006). In our study, bulk CD4+ and CD8+ T cells isolated from PBMCs could contain 
both naïve and memory T cell population. Hence, we cannot differentiate which 
population of T cells flagellin is costimulating. Future work has to include separating the 
memory and naïve T cell subsets to be tested with flagellin costimulation.  
It is evident that functions of TLRs are no longer only associated with the 
activation of cells of innate immunity such as dendritic cells. T cells also express TLRs, 
which can directly recognize costimulatory components associated with the pathogen, 
such as B. pseudomallei, to activate a costimulatory signaling pathway to augment T cell 
activation in synergy with TCR-mediated signals. Expression of TLRs by host cells to 
directly recognize bacterial costimulatory signals represents a mechanism for them to 
become activated leading to more efficient development of CMI responses against the 
pathogen. For instance, naive CD8+ and CD4+ T cells upon activation by antigenic and 
costimulatory signals, will proliferate and differentiate into effector T cells such as CD8+ 
cytotoxic T cells and cytokine secreting CD4+ helper T cells. We found that flagellin 
could costimulate both CD4+ and CD8+ T cells. Both subsets of T cells, by becoming 
activated through recognition of antigen-MHC complexes together with bacterial 
flagellin costimulus could lead to development of an efficient T cell-mediated immune 
response against the pathogenic bacteria.  
CD4+ T cells have been shown to be important for late host resistance to B. 
pseudomallei infection (Haque et al., 2006). B. pseudomallei flagellin can costimulate 
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CD4+ T cells, as shown for Jurkat CD4+ T cell line and primary human CD4+ T cells. 
During an infection, the bacterium itself can provide costimulatory signals leading to 
clonal expansion of antigen-specific CD4+ effector T cells, which are essential for 
mounting a cell-mediated immune response.  
Our study is also the first to demonstrate the costimulatory effects of flagellin on 
human CD8+ expressing T cells. These primary CD8+ T cells which we tested could 
consist of naïve or memory T cells, which were previously found in our laboratory to 
express TLR5 mRNA. CD44-high expressing memory CD8+ T cells isolated from spleen 
of uninfected mice were found to take part in bystander activation, where they could 
produce IFN-γ upon stimulation with gamma-irradiated B. pseudomallei 
(Lertmemongkolchai et al., 2001). These CD8+ memory T cells should express TLR5 
since memory CD4+ T cells expressed high levels of TLR5 (Crellin et al., 2005). The 
bystander activation could be a result of costimulation with B. pseudomallei flagelin. 
However, it is intriguing as to what is the source of the primary stimulus since the CD8+ 
T cells were taken from uninfected mice. Liu and co-workers (2006) have recently 
showed that IL-2 produced by effector T cells, can replace TCR signals (anti-CD3 
stimulation) in the model of BLP (TLR2 ligand) costimulation of regulatory T cells. In 
the above study by Lertmemongkolchai and group (2001) irradiated B. pseudomallei was 
used to stimulate bulk spleen cells, which would contain antigen-presenting cells (APCs). 
The APCs could be stimulated by the B. pseudomallei antigens to produce cytokines. At 
the same time, a small population of naïve T cells that express TCRs specific to B. 
pseudomallei antigens could be activated to produce IL-2. Cytokines produced by the 
APCs and antigen-specific T cells could serve as the primary stimulus, together with B. 
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pseudomallei costimulatory molecules such as flagellin, resulting in activation of 
memory T cells in a bystander fashion. Such as bystander activation of T cells could 
explain severe inflammation seen in acutely infected patients associated with high 
proinflammatory cytokine profiles. For instance, serum concentrations of soluble IL-2 
receptors and IFN-γ were observed to be highly elevated in septicemic melioidosis 
patients (Lauw et al., 1999, Brown et al., 1991). This could be a result of potent 
costimulatory signals on inducing T cell activation during infections with high bacterial 
loads. Future studies could examine whether flagellin could costimulate T cells in 
synergy with cytokine-mediated signals in addition to TCR signals. 
Ironically, flagellin that can potently costimulate T cells is also an essential 
component that makes up bacterial flagella, a virulence factor of B. pseudomallei (Chua 
et al., 2003). Hence, at the same time that bacterial costimulation can promote 
development of efficient host T cell responses, excessive inflammation may also occur if 
the costimulatory signal is inappropriately regulated leading to overexpansion of effector 
T cells. For instance, TLR2 agonist BLP was found to abrogate the suppressive function 
of regulatory T cell (Tregs) during the first 15 hours of stimulation, after which Tregs 
regained their suppressive capacity. This indicates that BLP-mediat 
ed abrogation of Tregs-mediated suppression of effector T cells is only a transient effect 
(Liu et al., 2006). Such an occurrence helps to prevent overexpansion of effector T cells 
that might lead to unwanted over-inflammation. In contrast to TLR2 studies, Crellin and 
co-workers showed that flagellin stimulation enhanced suppressive capacity of Tregs and 
FOXP3 expression, a transcription factor involved in suppressive functions of T regs. 
However, this is likely debatable since FOXP3 expression in Tregs was assessed 48 hours 
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after flagellin and anti-CD3 costimulation (Crellin et al., 2005). Hence, any transient 
abrogation of Treg function during earlier hours of stimulation with flagellin could be 
overlooked in this study. Further work is needed to study the effects of flagellin-TLR5 
costimulation in regulatory T cells.  
It has been shown that TLR4 ligand, LPS, did not possess costimulatory effects 
on upregulating effector T cell proliferation or cytokine production (Xu et al., 2005, 
Caron et al., 2005, Crellin et al., 2005). However, conflicting data is seen for regulatory 
T cells (Crellin et al., 2005, Caramalho et al., 2003). Recently, there are also several 
reports on TLR2 ligand BLP as a potent T cell costimulatory signal in enhancing 
proliferation of human CD4+ T cells (Xu et al., 2005, Liu et al., 2006). Hence, we 
investigated the costimulatory effects of both LPS and PAM on Jurkat T cells and found 
that both TLR agonists were unable enhance IL-2 production in response to anti-CD3 
stimulation. Jurkat T cells were shown not to express TLR2 or TLR4 mRNA in our 
laboratory, which could explain the observations. Importantly, the results indicate that in 
Jurkat cells, the costimulatory effect of flagellin with TCR stimulation on IL-2 
production could not be due to LPS or lipoprotein contamination of recombinant B. 
pseuomallei flagellin purified from E. coli. We also showed that LPS similarly had no 
costimulatory effect on primary human CD4+ and CD8+ T cells. In contrast, PAM could 
potently enhance IL-2 production by these cells upon TCR stimulation, consistent with 
current reports demonstrating potent costimulatory effects of BLP on human CD4+ T 
cells. Furthermore, HEK293T cells studies showed that the recombinant flagellin 
preparation used to costimulate the primary T cells was not contaminated by BLP. 
Therefore, it can be concluded that the enhanced IL-2 production in flagellin 
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costimulated Jurkat CD4+ T cells as well as human CD4+ and CD8+ T cells was due to 
the effects of flagellin-TLR5 costimulation. 
 CD4+CD25- effector T cells and CD4+CD25+ Treg cells, which have not been 
activated with TCR signals, were shown to express TLR5 at levels within the range of 
monocytes. In particular, T regs expressed significantly higher amounts of TLR5 than the 
effector counterparts (Crellin et al., 2005). It was also shown that TLR5 mRNA levels 
were reduced dramatically in CD4+ effector as well as regulatory T cells after 24 hours of 
activation with anti-CD3/ anti-CD28 mAbs (Crellin et al., 2005). In contrast, we detected 
an upregulation of TLR5 mRNA transcript level at 5 hours after anti-CD3 stimulation. 
This suggests that TLR5 mRNA could be transiently upregulated shortly after TCR 
stimulation. Since TCR ligation alone is insufficient for T cell activation and a second 
costimulatory signal is required, naïve T cells primed by antigenic signals could 
transiently upregulate TLR5 expression to recognize bacterial costimulatory signals to 
enable full T cell activation.  
Enhanced cytokine production by flagellin costimulation has so far been detected 
only at the protein level (Caron et al., 2005, Crellin et al., 2005). Using reverse 
transcription and real time PCR techniques, we demonstrated that the increased IL-2 
secretion by Jurkat T cells upon CD3 and flagellin costimulation could be correlated to 
increased IL-2 mRNA transcript expression levels. This suggests that TLR5 signaling 
synergizes with that of TCR to enhance IL-2 production largely through the activation of 
transcription to promote increased IL-2 gene transcription. 
Although flagellin costimulation resulted in very high levels of IL-2 mRNA 
transcript levels, we found that it did not result in enhanced IL-2 mRNA stability during 
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the first hour of cyclosporin A (CsA) addition. However, enhancement of mRNA stability 
could be observed between 1 to 2 hours after CsA addition. Later time points after CsA 
addition should be looked at in future to better conclude on the effects of flagellin on 
mRNA stabilization. It has been reported that CD28-mediated activation of PI3 kinase 
(PI3K) led to an upregulation of IL-2 transcription in DO11.10 TCR-transgenic mice T 
cells, which accounted for the increased IL-2 secretion by the T cells upon CD28 
costimulation. At the same time, CD28 costimulation also led to enhanced IL-2 secretion 
through posttranscriptional regulation involving the stabilization of IL-2 mRNA mediated 
through a PI3-kinase independent pathway (Sanchez-Lockhart et al., 2004 and Sanchez-
Lockhart and Miller, 2006).     
In our study, we found that flagellin costimulation enhanced IL-2 transcript 
expression to a significantly greater extent compared to CD28 costimulation, although 
both costimuli resulted in a similar degree of enhancement in IL-2 secretion in T cells. It 
is possible that CD28-mediated enhancement of IL-2 mRNA stability could account for 
high levels of IL-2 secretion even though transcript expression was enhanced to a smaller 
extent. In fact, CD28 costimulation appeared to stabilize IL-2 mRNA after the first hour 
of inhibition of T cell transcription by CsA compared to untreated cells, while IL-2 
mRNA in flagellin costimulated T cells dropped to very low levels quickly during the 
first hour of CsA addition. Hence, flagellin costimulation could primarily enhance IL-2 
secretion in Jurkat cells through significantly augmenting mRNA transcript generation 
and possibly by stabilizing mRNA at later time points. 
The stability of IL-2 mRNA is mainly controlled by adenosine- or uridine-rich 
elements (ARE) in the 3’-untranslated region (Kracht and Saklatvala, 2002, Raghavan et 
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al., 2002 and 2004). IL-2 mRNA stability is controlled by c-Jun amino-terminal kinase 
(JNK) (Chen et al., 1998). p38 MAP kinase has also been implicated in mediating mRNA 
stability of IL-2 (Mestas et al., 2005). However, proximal signals induced by CD28 
costimulatory receptor to induce IL-2 mRNA stability have not yet been elucidated 
(Sanchez-Lockhart and Miller, 2006). Nonetheless, our study suggests some differences 
in the mechanism by which TLR5 and CD28 costimulation synergizes with TCR 
signaling to enhance IL-2 production in T cells.  
TLR5 and TCR signaling pathways have been well studied. Ligation of TLR5 is 
followed by recruitment of receptor-proximal adaptor MyD88 that binds to IRAK-1, 
which phosphorylates TRAF6 leading to activation of IKK molecules, degradation of IκB 
and subsequent activation of NF-κB transcription factor (Hayashi et al., 2001, Gohda et 
al., 2004). In innate immune cells such as DCs, flagellin-TLR5 signaling stimulates their 
maturation and cytokine production with NF-κB activation being detected in these cells 
(Means et al., 2003, Didierlaurent et al., 2004). TCR ligation also leads to NF-κB and 
AP1 activation through PKCθ involving Carma1, a scaffolding protein required for the 
coupling of TCR ligation to activation of IKK signalsome (Wang et al., 2004, Thome and 
Tschopp, 2003). Hence, synergistic effects of TLR5 signaling with TCR signals could be 
achieved through enhancing the activation of transcription factors such as NF-κB to 
promote increased IL-2 gene transcription.  
CD28 is a crucial T cell costimulatory receptor that potently enhances IL-2 
production by antigen-specific human T cells (Jenkins et al., 1991). T cells stimulated 
with antigen in the absence of the CD28 signal also become anergic (Jenkins et al., 
1987). The CD28 response element (CD28RE) has also been identified as the DNA 
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element mediating IL-2 gene activation by CD28 costimulation (Fraser et al., 1991). 
Functional regulation of the CD28RE within the IL-2 promoter is mediated by NF-κB 
transcription factors (Verweij et al., 1991, Ghosh et al., 1993, Lai et al., 1995). CD28 as 
well as TLR5 costimulation, can trigger NF-κB activation to enhance TCR-mediated 
signals as seen by our observations of additive effects on augmenting IL-2 production in 
T cells upon TCR engagement when TLR5 ligand flagellin was supplied together with 
anti-CD28. This could possibly be a result of additive effects on enhancing NF-κB 
activation. Other transcription factors involved in activation of IL-2 gene transcription by 
TCR and CD28 includes nuclear factor of activated T cells (NFAT) (Maggiwar et al., 
1997) as well as AP1 (c-fos and c-jun) (McGuire and Iacobelli, 1997). TRAF6 adaptor 
molecule downstream of TLR signaling mediates AP1 activation through MAP kinases 
that activate AP1 components (Bradley and Pober, 2001, Dong et al., 2002, Tanoue and 
Nishida, 2003). Hence, TLR5 signaling could also synergize with TCR signaling 
pathways at junctures other than NF-κB activation.  
Unlike other TLRs found to be localized within intracellular compartments, TLR5 
signaling occurs at the cell membrane and does not require internalization (West et al., 
2005). Thus, we should study in future whether TLR5 is colocalized with TCR within the 
central supramolecular activation cluster (c-SMAC), which has been found to be enriched 
for TCR, CD4 and CD28 coreceptors along with crucial signaling effectors such as PKCθ 
and Lck (Huppa and Davis, 2003). Colocalization of TLR5 within the c-SMAC could 
indicate that both signaling pathways merge at this site as in the case for CD28. CD28 
costimulation has been reported to activate PI3K to induce recruitment of PKCθ into the 
c-SMAC region as well as nuclear localization of NF-κB (Sanchez-Lockhart et al., 2004). 
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VAV1 signaling intermediate also potently upregulates CD28-induced activation of 
transcription factors that regulate IL-2 gene transcription such as NF-κB and NFAT 
(Michel et al., 2000, Marinari et al., 2002). It has also been shown that NF-κB activation 
is mediated by recruitment of signaling effectors other than PKCθ, such as Bcl-10 and 
IκB kinase beta to the immunological synapse involving Carma 1 (Wang et al., 2004). 
Hence, future work could include determining if crucial TCR signaling intermediates 
such as PKCθ are similarly recruited to the c-SMAC region or if CD28 costimulatory 



























































We showed that B. pseudomallei could invade and replicate intracellularly in T 
cells. T cells are central players of cell-mediated immunity, which is important for the 
eradication of intracellular pathogens such as B. pseudomallei. Intracellular persistence of 
B. pseudomallei could account for latent infections and disease relapse from reactivation 
of an endogenous bacterial source.  
Upon infection, it is necessary for the host to efficiently evoke an appropriate 
immune response to eradicate the pathogen before overwhelming bacterial loads from 
uncontrolled bacterial replication tears down the body’s system. Recent clinical studies 
have demonstrated the development of cell-mediated immunity during B. pseudomallei 
infection (Ketheesan et al., 2002 and 2004) CD4+ T cells have also been shown to be 
important for late host resistance to B. pseudomallei infection in a mouse model (Haque 
et al., 2006). Altering cellular functions or inducing cell death of host immune cells such 
as T cells represents means by which B. pseudomallei could cripple host adaptive 
immunity. We found that live virulent B. pseudomallei did not induce rapid cell death in 
T cells. In addition, during the period of bacterial and host cell coexistence, the pathogen 
did not negatively alter T cell activation signaling. Instead, enhanced T cell activation, 
indicated by increased IL-2 production by T cells, in response to TCR antigenic signals 
was observed. IL-2 is an essential autocrine T cell growth factor cytokine that leads to 
clonal expansion of antigen-primed effector T cells.  
Such a costimulation effect by bacterial flagellin on host T cells could represent a 
host mechanism to more efficiently develop CMI responses against the pathogen. During 
infection, B. pseudomallei can provide the primary antigenic signal as well as 
costimulatory signal such as flagellin, to result in enhanced T cell activation and 
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subsequent clonal expansion of antigen-specific effector CD4+ and CD8+ T cells to better 
fight against the pathogen. Our study is also the first to show that bacterial flagellin can 
costimulate CD8+ expressing T cells. The discovery of potent T cell costimulatory 
molecules associated with the pathogen and how the host immune cells respond to them 
will also expand the search for vaccine candidates that are capable of evoking efficient 
CMI protection in the host during B. pseudomallei infection.  
However, such potent T cell costimulatory effects by B. pseudomallei could also 
account for overt pathophysiology associated with acute septicemic melioidosis. In such a 
case, overwhelming bacterial load could lead to an overexpansion of effector T cells and 
their increased pro-inflammatory cytokine as a result of strong T cell costimulation by 
bacterial components. For instance, it has been shown that IL-2 produced by effector T 
cells could replace primary antigenic signals in the model of costimulation of regulatory 
T cells by TLR2 ligand (Liu et al., 2006). Cytokines produced by APCs and by antigen-
specific T cells could serve as the primary stimulus, which together with B. pseudomallei 
costimulatory molecules, can activate memory T cells. Such a bystander activation could 
account for severe inflammation seen in acutely infected patients associated with a high 
pro-inflammatory cytokine production profile.  
Furthermore, although flagellin has been shown to enhance the suppressive 
capacity of regulatory T cells, it is not sure if flagellin could transiently abrogate 
suppressive function of regulatory T cells as in the case of TLR2 ligand, which could lead 
to over expansion of antigen-specific effector T cells (Liu et al., 2006). Hence, 
unregulated potent costimulation of T cells by bacterial costimulatory components may 































Despite the clinical importance of melioidosis especially in endemic regions, the 
pathogenesis of Burkholderia pseudomallei is not fully understood. Understanding the 
pathogenesis of the bacterium is important for effective therapeutic developments. 
By employing an in vitro cell culture method, we showed that B. pseudomallei 
has the ability to invade and replicate intracellularly within T cell lines. The mechanisms 
by which the bacteria can survive within T cells has not been elucidated. Future work 
could include mutagenesis studies to identify virulence components responsible for 
invasion and intracellular replication within these cells. Ex vivo studies should also be 
carried out to examine the capacity of B. pseudomallei to invade and replicate in primary 
human DCs and T cells isolated from PBMCs.  
Others in the laboratory had previously shown that B. pseudomallei induced rapid 
cell death in human DCs (Sun et al., 2005). The bacterium has previously been shown to 
induce rapid cell death in macrophages via a caspase-1-dependent pathway.  
Interestingly, we did not observe rapid cell death in B. pseudomallei infected T cell lines. 
Future studies could focus on how T cells can overcome bacterial induced cell death 
during early hours of infection.  
Both experimental and clinical studies have demonstrated the importance of CMI 
responses, especially that mediated by T cells, in the control of B. pseudomallei infection.  
However, it is uncertain whether B. pseudomallei could directly alter functions of T cells, 
the essential players in adaptive immune responses. Our study is the first to reveal that 
infection with live B. pseudomallei did not negatively affect T cell activation in terms of 
their ability to produce IL-2. In fact, we found that live B. pseudomallei could 
costimulate T cells to enhance TCR-mediated signals resulting in increased IL-2 
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production compared to uninfected T cells. Memory lymphocytes taken from individuals 
with prior exposure to B. pseudomallei were found proliferate in response to B. 
pseudomallei lysate (Ketheesan et al., 2002). B. pseudomallei costimulatory signals could 
enhance such lymphocytic responses. Therefore, it is also important to examine the 
effects of bacterial costimulation on different subset of T cells including regulatory and 
memory T cells.  
Flagellin protein, found in B. pseudomallei supernatant, was found to be the main 
costimulatory component secreted by the bacteria. Our study essentially provides new 
insights as to how the pathogen can directly costimulate naïve human T cells. Future 
studies could include determining other parameters of T cell activation such as 
proliferation, upregulation of surface activation markers, cytotoxic function and 
production of other cytokines as well as maintenance of memory T cells. Importantly, 
future work should focus on discovery of costimulatory components other than flagellin 
that appear to be associated with live B. pseudomallei. The discovery of potent T cell 
costimulatory components associated with the pathogen and how the host T cells respond 
to them will extend vaccine candidate options for protection against B. pseudomallei 
infection. This is especially so since effector T cells are known to be important for host 
defenses against this pathogen.  
Recently, a group has reported that BLP (TLR2 ligand), together with IL-2 
produced by effector T cells, could result in enhanced proliferation of regulatory T cells 
(Liu et al., 2006). This indicates that IL-2 can replace TCR signals (anti-CD3 
stimulation) in the model of BLP costimulation of T regs. Hence, future studies could 
 115 
include examining whether B. pseudomallei costimulatory molecules can synergistically 
enhance T cell responses with cytokine-mediated signals as the primary stimuli. 
B. pseudomallei flagellin is able to costimulate T cells, and is at the same time a 
virulence factor (Chua et al., 2003). This has an implication in overt pathology seen in 
septicemic patients or acute infection mice models, which could be accounted for by an 
overexpansion of effector T cells and increased production of proinflammatory cytokine 
triggered by potent costimulatory signals associated with the pathogen.  
Costimulatory signals are necessary to prevent T cell anergy after antigen 
recognition (Jenkins et al., 1987). Costimulation by B. pseudomallei could prevent 
bacterial-induced activation-induced cell death in antigen specific T cells. For instance, 
CD28 costimulation was associated with an increased expression of anti-apoptotic protein 
Bcl-xL that could prevent activation induced cell death (Khoshnan et al., 2000). It will be 
interesting to find out if B. pseudomallei costimulation of T cells similarly resulted in 
enhanced expression of anti-apoptotic proteins, which could explain why infected T cells 
might not be susceptible to bacterial-induced death during early hours of infection.  
Recent studies have been focused on elucidating the roles of TLRs as T cell 
costimulatory receptors. Our study showing that flagellin associated with live bacteria as 
well as recombinant B. pseudomallei flagellin could potently augment IL-2 production in 
synergy with TCR signals is consistent with current literature reports. However, it will be 
important to discover next how TLR5 signaling synergizes with the TCR signaling 
pathway at the molecular level. CD28 costimulation has been well characterized over the 
years. Hence, initial signaling investigations can be based on paralleling TLR5 
costimuation pathways to that mediated by CD28 to identify any similarity in molecular 
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mechanisms of synergy with TCR pathways. For instance, we can determine whether as 
in the case of CD28, TLR5 colocalizes with TCR within the central supramolecular 
activation cluster (c-SMAC) that is known to be enriched for TCR, its associated 
coreceptors as well as crucial signaling effectors. This can help us to identify the site at 
which the TLR and TCR signaling pathways merge. We can also examine if TLR5 
costimulation results in recruitment of important TCR signaling molecules such as PKCθ 
and Lck to the c-SMAC region. Our data suggest an additive effect with flagellin and 
CD28 costimulation. Hence, we could determine if TLR5 costimulation involves 
activation of transcription factors shared by CD28 such as NF-κB, NFAT and AP1 that 
regulate IL-2 gene transcription, and whether upstream effectors such as those shared by 
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Complete RPMI 1640: RPMI 1640, 10 % FCS, 200 mM L-glutamine, 100 units/ml 
penicillin and 100 µg/ml streptomycin 
Blocking buffer for ELISA: PBS, 1.0 % BSA  
Blocking buffer for Western Blotting: TBS-T, 5 % BSA 
LB Medium: 10 g / liter bacto-tryptone, 5 g / liter bacto yeast extract, 5 g / liter NaCl. pH 
was adjusted to 7.0 with 2N NaOH 
Lysis Buffer: PBS, 1 % Triton X-100 
MACS de-gassed buffer: PBS, 2 mM EDTA, 1 % FBS, pH 7.2 
PBS: 137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, pH 7.4 
Stop solution for ELISA: deionized water, 0.5 M H2SO4 
TBS-T: 20 mM Tris-HCL, 500 mM NaCl, 0.05% Tween-20, pH 7.5. 
TSA: Pancreatic digest of casein 15.0 g / liter, Papaic digest of soybean meal 5.0 g / liter, 
NaCl 5.0 g / liter, Agar 5.0 g / liter, pH 7.3 
Wash buffer for ELISA: PBS, 0.05 % Tween-20 
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